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Abstract 
The increasing incidence of infections due to antibiotic resistant bacteria has led to 
renewed interest in bacteriophages (= phages) and phage therapy. Although phage 
therapy has been applied to control bacterial diseases in plants, poultry, livestock and 
humans, its application in aquaculture is still relatively limited. The emergence of 
phage-resistant bacterial mutants has been considered to be one of the major 
limitations of phage therapy. This study aimed to (i) isolate and characterise phages; (ii) 
select phages and their bacterial hosts to set up in vivo phage therapy models with 
aquaculture animals, and estimate the efficiency of phage therapy; (iii) investigate the 
generation and characteristics of phage-resistant mutants, and thus estimate the 
consequence of applying phage therapy when phage-resistant mutants emerge; and 
(iv) discuss the prospects for application of phages in aquaculture. 
 
Two Vibrio isolates and their phages were isolated from a Scottish marine fish farm. 
Based on the results of conventional phenotype testing and 16S rRNA gene sequencing 
analysis, the two vibrios, V9 and V13, were identified as Vibrio splendidus and Vibrio 
cyclitrophicus, respectively. The bacterial characteristics including morphology, 
temperature and salinity range of growth, production of extracellular enzymes, and 
the possession of virulence genes were examined. According to the morphological 
characteristics observed using transmission electron microscopy by negative staining, 
phage PVS9 of V. splendidus V9 was identified as a myophage, while phage PVC13 of V. 
cyclitrophicus V13 was identified as a siphophage. The phages could only lyse one 
bacterial host strain and their genomic DNA was double stranded with a size of ~46 kb. 
The two Vibrio isolates were found to be non- or of low virulence to rainbow trout, 
goldsinny wrasse and Artemia in pathogenicity experiments. Thus an in vivo phage 
therapy model could not be set up using these Vibrio isolates and their phages. 
 
 
Two phages pAS-3 and pAS-6 were isolated using the Aeromonas salmonicida subsp. 
salmonicida Hooke strain as the host. Phages pAS-3 and pAS-6 had a similar genome 
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size of ~50 kb, and the same relatively narrow host range within A. salmonicida subsp. 
salmonicida strains. The siphophage pAS-3 formed clear plaques and inhibited A. 
salmonicida Hooke growth in vitro completely for at least 18 hours when using MOI = 
1,000, whereas the podophage pAS-6 formed turbid plaques and weakly inhibited 
Hooke growth. Rainbow trout exposed by intraperitoneal injection with 0.1 mL of the 
raw phage preparations at a concentration of 108 PUF mL-1 showed no adverse effects 
over 14 days. In the phage therapy trial, fish were firstly injected with 1 x 102 CFU fish-1 
of A. salmonicida Hooke, then immediately injected with phage preparations of pAS-3 
and pAS-6, respectively, using MOI = 10,000. Compared with the control group (which 
did not receive phage treatment), phage treated groups showed a delay in the time to 
death, and lower mortalities. However, the mortalities and time to death between 
phage treated and non-treated groups were not significantly different.  
 
Phage-resistant mutants of pathogenic A. salmonicida strain Hooke were induced by 
repeatedly challenging with phage pAS-3. One of the mutants, termed HM, was 
chosen to compare the characteristics with the parental wild-type strain Hooke. Test 
results including the formation of ‘smooth’ colonies on TSA, autoagglutination 
negative, the formation of creamy colonies on Coomassie Brilliant Blue agar, and the 
degradation of a thick/furry layered structure on the cell surface indicated a deficiency 
of the A-layer in the phage-resistant mutant HM. Therefore, it was deduced that the A-
layer either directly acted as the receptor of A. salmonicida phage pAS-3, or was 
affected indirectly by the change of an unknown phage receptor. The greater wax 
moth larvae model was used to compare the virulence of the phage-resistant mutant 
HM and the parental wild-type strain Hooke, as it is an ethically acceptable animal 
model, which has the advantages of being low cost and convenient for injection, and is 
also a recognised alternative model for bacterial pathogens of fish. The results showed 
that virulence of the phage-resistant mutant HM did not decline in the greater wax 
moth larvae model compared with that of the parental wild-type strain Hooke. 
 
In conclusion, different approaches were used to isolate and characterise phages from 
different aquaculture environments for potential use in phage therapy. A rainbow 
trout model was set up using pathogenic A. salmonicida strain Hooke and two A. 
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salmonicida phages pAS-3 and pAS-6. The use of phage treatment led to lower 
cumulative mortalities and delay to the time of death, although the differences 
between the groups were not significant, futher work is required to determine if these 
phages have potential in phage therapy. The consequence of applying phage therapy 
when phage-resistant mutants emerge was estimated based on their characteristics 
and virulence, and no decline in virulence of the phage-resistant mutant from this 
study indicates the importance of fully testing the virulence of phage-resistant 
mutants before carrying out large scale field trials of phage therapy. It appears feasible 
to use phage therapy as an alternative approach to control bacterial infections in 
aquaculture, but further studies are required to focus on improving effectiveness, and 
also to overcome the concrete limitations and hurdles in application and 
commercialisation. Moreover, a broader range of applications of phages in 
aquaculture should be explored. 
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1.1 Aquaculture 
1.1.1 Definition of aquaculture 
Aquaculture is an ancient farming activity, and may be traced back to China more than 
4,000 years ago, when common carp (Cyprinus carpio) were raised for food in fresh 
water ponds (Pillay & Kutty, 2005). The term, aquaculture, is derived from the Latin 
‘aqua’ and ‘colere’, which mean ‘water’ and ‘to care for’, respectively. Aquaculture has 
been defined in many ways: macro-aquaculture includes all activities where it is aimed 
at producing, processing and marketing aquatic animals and plants from fresh, 
brackish and sea water. The most current and internationally accepted definition has 
been given by the Food and Agriculture Organization (FAO) of the United Nations (UN), 
as ‘the farming of aquatic organisms including fish, molluscs, crustaceans and aquatic 
plants. Farming implies some sort of intervention in the rearing process to enhance 
production, such as regular stocking, feeding, and protection from predators’ (FAO, 
1995).   
1.1.2 Global aquaculture 
Aquaculture is a globally important and is currently the fastest growing food producing 
sector, which provides almost half of all fish for human consumption. In 2012, global 
aquaculture production attained another all-time high of 90.4 million tonnes (US$ 
144.4 billion), including 66.6 million tonnes of food fish (US$ 137.7 billion) and 23.8 
million tonnes of aquatic algae (mostly seaweeds, US$ 6.4 billion) (FAO, 2014). In 
addition, 22, 400 tonnes of non-food products (US$ 222.4 billion), such as pearl 
oysters and seashells for ornamental and decorative uses, was also reported 
collectively by some countries (FAO, 2014). China is the largest aquaculture producer 
who is diversified in terms of aquaculture species and farming systems (FAO, 2014). In 
2012, Asia accounted for about 88 % of world aquaculture production by volume, and 
China contributed 61.7 % in the world total farmed food fish production, followed by 
India, Vietnam, Indonesia and Bangladesh as the top five countries (FAO, 2014). As at 
2012, there has been 567 species registered in FAO statistics as the species produced 
in aquaculture, including finfishes (354 species, with 5 hybrids), molluscs (102), 
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crustaceans (59), amphibians and reptiles (6), aquatic invertebrates (9), and marine 
and fresh water algae (37). Carp is the most produced fish in the world, due to the vast 
scale of aquaculture in Asia. Salmonids are the most produced mariculture fish, whose 
biggest producer is Norway (FAO, 2014; Lillicrap, et al., 2015).  
1.1.3 Aquaculture in Scotland 
Aquaculture is an increasingly important industry for Scotland, helping to sustain 
economic growth in the rural and coastal communities of the North and West. 
Involving the farming or culturing of fish, molluscs, crustaceans and seaweed, 
aquaculture produces the most valuable food exports of Scotland 
(http://www.gov.scot/Topics/marine/Fish-Shellfish). The aquaculture industry in 
Scotland is led by Atlantic salmon (Salmo salar) farming, and Scotland is currently the 
largest producer of farmed Atlantic salmon in the EU and third largest globally, but 
also produces significant quantities of rainbow trout (Oncorhynchus mykiss) and 
mussels (Mytilus spp.) (http://www.scotland.gov.uk/Topics/marine/Fish-
Shellfish/FactsandFigures).   
 
In 2014, Scotland produced 179,022 tonnes of Atlantic salmon, 5,882 tonnes of 
rainbow trout, 66 tonnes of halibut (Hippoglossus hippoglossus), 48 tonnes of brown 
trout (Salmo trutta), 5 tonnes of lumpsucker (Cyclopterus lumpus), and 0.1 tonnes of 
wrasse (Labridae) (Munro & Wallace, 2015), as well as 7,683 tonnes of mussels, 
3,392,000 shells of Pacific oysters (Crassostrea gigas), 242,000 shells of native oysters 
(Ostrea edulis), 18,000 shells of queen scallop (Chlamys opercularis) and 48,000 shells 
of scallop (Pecten maximus) (Munro & Wallace, 2015). The Scottish aquaculture 
industry has plans for expansion of aquaculture with the aim of increasing marine 
finfish (including farmed Atlantic salmon) production sustainably to 210,000 tonnes, 
and shellfish (particularly mussels) production to 13,000 tonnes sustainably by 2020 
(Scotland’s National Marine Plan, the Scottish Government, 2015). 
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1.1.4 Bacterial diseases of fish 
Cultured fish sustains greater stresses than fish in the wild (Dallaire-Dufresne et al., 
2014). High stocking densities, low levels of dissolved oxygen, environmental pollution 
and inappropriate management practices are associated with the onset of diseases in 
aquaculture (Barton & Lwama, 1991; Dallaire-Dufresne et al., 2014). Infectious 
diseases, which may be caused by bacteria, viruses, parasites and fungi concentrated 
in culture systems, may lead to mortality and significant economic disruptions (Diana 
et al., 2013). A wide variety of bacterial pathogens are involved in salmonid diseases, 
including Aeromonas hydrophila (haemorrhagic septicaemia; fin/tail rot), A. 
salmonicida (furunculosis; ulcer disease), Flavobacterium psychrophilum (rainbow 
trout fry syndrome, RTFS), Flexibacter spp. (gill disease, black patch necrosis), 
Mycobacterium spp. (mycobacteriosis), Pseudomonas spp. (generalised 
septicaemia/haemorrhagic ascites/ulceration), Renibacterium salmoninarum (bacterial 
kidney disease; Dee disease, corynebacterial kidney disease), Streptococcus spp. 
(streptococcicosis), Vibrio spp. (vibriosis) and Yersinia ruckeri (enteric redmouth 
disease, ERM) (Austin & Austin, 2012). Typical A. salmonicida and Vibrio spp. are the 
focus of this study. 
1.2 Aeromonas salmonicida subsp. salmonicida 
1.2.1 The organism 
Aeromonas salmonicida belongs to the genus Aeromonas, family Aeromonadaceae, 
order Aeromonadales, and class Gammaproteobacteria. It is composed of five 
subspecies: salmonicida, achromogenes, masoucida, smithia, and pectinolytica (Beaz-
Hidalgo & Figueras, 2013). The isolates, which are identified as A. salmonicida subsp. 
salmonicida, are generally referred to as typical A. salmonicida that is related with the 
systemic infection in salmonids commonly referred to as furunculosis. The four other 
subspecies and the isolates that cannot be classified in any of the five subspecies are 
generally considered as atypical A. salmonicida that often cause ulceration in non-
salmonids, such as cyprinids and including some marine flatfish (Burr & Frey, 2007; 
Austin & Austin, 2012; Dallaire-Dufresne et al., 2014). 
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Aeromonas salmonicida subsp. salmonicida (= A. salmonicida) is characterized as 
Gram-negative, non-motile, and facultative anaerobic bacilli (short rods), normally 
associated with the production of a brown, water soluble, diffusible pigment when 
grown in medium containing tyrosine or phenylalanine (Dallaire-Dufresne et al., 2014). 
The optimum growth temperature of A. salmonicida is between 22 and 25 ℃. 
However, even growing A. salmonicida in this optimum temperature range may lead 
to the loss or inactivation of some virulence genes (Ishiguro et al., 1981; Stuber et al., 
2003; Daher et al., 2011). Therefore, it has been recommended to culture A. 
salmonicida below 20 ℃ (Dallaire-Dufresne et al., 2014). When cultured on agar plates 
at 18 ℃, colonies of A. salmonicida are pinhead size after 18-24 hours, and then 
become circular, convex, and entire with a diameter of 1-2 mm after 3 days. An 
interesting characteristic of A. salmonicida is the ability to form different colony types, 
classified as rough, smooth and the intermediate type (= G-phase). This phenomenon 
was attributed to the presence (rough) or absence (smooth) of an extracellular layer 
(A-layer) as demonstrated by electron microscopy (Austin & Austin, 2012). 
1.2.2 Virulence factors 
A number of virulence factors that are related with the diseases caused by A. 
salmonicida have been studied, including an extracellular layer (= A-layer), a type III 
secretion system (TTSS) and a variety of extracellular molecules (Daher et al., 2011; 
Beaz-Hidalgo & Figueras, 2013).  
 
The A-layer is the additional layer, external to the cell wall. It is a complex protein 
structure associated with lipopolysaccharides (LPS) (Dallaire-Dufresne et al., 2014). 
The A-layer protein is encoded by a single chromosomal gene, termed vapA (Belland & 
Trust, 1985; Reith et al., 2008), and its assembly requires the presence of O-
polysaccharide chains (Dooley et al., 1989). The A-layer is responsible for bacterial 
autoagglutination, adherence to host tissues and resistance to phagocytosis. In 
addition, this layer may protect the cell from serum complement and the action of 
protease (Austin & Austin, 2012). In some cases, the A-layer acts as a phage receptor 
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(Rodgers et al., 1981; Ishiguro et al., 1984), while in others, it shields phage receptors 
in the outer membrane (Ishiguro et al., 1981). Normally, the A-layer can be detected 
using Coomassie Brilliant Blue agar (CBBA) (Evenberg et al., 1985) and Congo Red agar 
(Ishiguro et al., 1985). The A-layer positive strains form dark blue and red-coloured 
colonies on CBBA and Congo Red agar, respectively, whereas the A-layer negative 
strains appear white (Buller, 2004). The production of the A-layer can be related to the 
culture temperature of A. salmonicida, and it was considered that growing the 
bacterium above 20 ℃ may lead to the loss of the A-layer protein (Daher et al., 2011). 
Even though many studies have proven the association between the possession of an 
A-layer and virulence (Ishiguro et al., 1981; Kay et al., 1981; Han et al., 2011), there are 
exceptions. For example, virulent A-layer negative isolates (Ellis et al., 1988; Bernoth, 
1990), and non-virulent A-layer positive isolates (Olivier, 1990) have been reported. 
 
The function of the TTSS in A. salmonicida is to secrete and translocate toxins 
(effectors) from the bacterial cytoplasm to the host cell (Burr et al., 2002; Stuber et al., 
2003). The vast majority of the proteins required for the formation and regulation of 
the TTSS are encoded by the tandem of genes located on the large pAsa5 plasmid, 
while the effector, i.e. the ADP-ribosylating toxin (AexT), is encoded by the aexT  gene 
located on the chromosome (Reith et al., 2008). Both Daher et al. (2011) and Tanaka 
et al. (2013) demonstrated that the expression of the TTSS is temperature-dependent, 
supported by the evidence that growing A. salmonicida at temperatures above 22 ℃ 
caused the re-arrangement of the plasmid pAsa5, which resulted in the loss of the 
TTSS region and virulence. Studies that used mutant deficient strains have revealed 
that the structural genes of the TTSS are essential for the virulence of A. salmonicida 
(Burr et al., 2005; Dacanay et al., 2006). In addition, Fast et al. (2009) suggested that 
both the structural proteins of the TTSS and the effector proteins probably have an 
impact on the survival of A. salmonicida within the host immune cells. 
 
Aeromonas salmonicida produces a large variety of extracellular molecules as 
virulence factors, including proteases, lipases and haemolysin (Ellis et al., 1988; 
Dallaire-Dufresne et al., 2014). These enzymes are more likely related in the infection 
process especially in the degradation of the host tissues (Daher et al., 2011). The 
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haemolysin in A. salmonicida is correlated with lesion development and rapid death in 
rainbow trout (Ellis et al., 1988; Beaz-Hidalgo & Figueras, 2013). A 64-kDa serine 
protease, named AspA, can liquefy the muscle tissues and cause furuncles on the 
infected fish (Fyfe et al., 1986). The glycerophospholipid–cholesterol acyltransferase 
(GCAT) lipase hydrolyses membrane phospholipids, resulting in lysis of fish 
erythrocytes and also binds to LPS to form a high molecular weight toxin (Lee & Ellis, 
1990; Vipond et al., 1998). However, in the study of Vipond et al. (1998), differences 
were not recorded in virulence between the GCAT or AspA mutants and the parental 
strain in an Atlantic salmon challenging model. 
1.2.3 Furunculosis 
Furunculosis (Figure 1.1) is a systemic disease of salmonids, and is characterised by 
high mortality and morbidity (Burr et al., 2005; Austin & Austin, 2012). The disease 
spreads through contact with infected fish or simply by exposure to the water 
contaminated with A. salmonicida (Dallaire-Dufresne et al., 2014). The name 
‘furunculosis’ is derived from the presence of furuncles or boils that develop on the 
skin and musculature of fish, which are affected by the sub-acute or chronic form of 
the disease (Austin & Austin, 2012). However, furunculosis is a complex disease, which 
develops different clinical manifestations depending on the age, species, and health 
conditions of fish, and even environmental conditions, especially temperature (Boyd et 
al., 2003). The sub-acute or chronic form of furunculosis is more common in older fish, 
which often have furuncles (Austin & Austin, 2012). The infections are characterised 
by the clinical signs of lethargy, slight exophthalmia, blood-shot fins, bloody discharge 
from the nares and vent, and multiple haemorrhages in the muscle and other tissues, 
as well as haemorrhaging in the liver, swelling of the spleen, and kidney necrosis 
(Austin & Austin, 2012).  This form of the disease is usually of slow-onset with low 
rates of mortality. The acute form of furunculosis happens more commonly in growing 
and adult salmonids, which causes a rapid and general septicaemia accompanied by 
melanosis, inappetance, lethargy, and haemorrhages at the base of the fins as well as 
the abdominal wall, viscera and heart (Austin & Austin, 2012). Such infections usually 
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are of sudden onset, and cause high mortalities in two to three days (Boyd et al., 2003; 
Burr et al., 2005; Austin & Austin, 2012). 
 
Figure 1.1 A furuncle caused by Aeromonas salmonicida subsp. salmonicida on the 
surface of a rainbow trout. Adapted from Austin & Austin (2012). 
1.2.4 Prophylaxis and therapy 
Vaccines have been generally successful in farmed Atlantic salmon (Håstein et al., 
2005; Gulla et al., 2015). At present, all farmed Atlantic salmon in Norway, 
approximately 320 million fish per year, are vaccinated prior to sea transfer (Romstad 
et al., 2013). Different vaccine formulations and methods of administration have been 
attempted on salmonids with varying degrees of protection (Villumsen et al., 2015). 
The oil-adjuvanted vaccines, administrated by intraperitoneal (i.p.) injection, are the 
most common type of vaccines used in the aquaculture industry, and have achieved 
high levels of protection in trout and salmon with heightened and prolonged antibody 
response (Håstein et al., 2005; Villumsen et al., 2012; Romstad et al., 2013). However, 
application of oil-adjuvanted vaccines has also shown a number of adverse effects, 
including the presence of lesions at the injection sites, intra-abdominal adhesions, 
pigmentation, granulomas, autoimmunity, spinal deformities, transitory anorexia and 
reduction in growth, as well as long-term inflammation (Midtlyng, 1996; Mutoloki et 
al., 2004; Sørum & Damsgård, 2004; Berg et al., 2006; Haugarvoll et al., 2010; Satoh et 
al., 2011).  
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Applying chemotherapeutic agents (antibiotics) is another invaluable way for stopping 
heavy mortalities during outbreaks of furunculosis (Austin & Austin, 2012). Quinolone 
antibiotics, principally oxolinic acid and flumequine are used most frequently to treat 
furunculosis (Giraud et al., 2004). However, using chemotherapy leads to the rapid 
emergence of antibiotic resistant bacteria, even multiple resistant strains (Inglis et al., 
1991; McIntosh et al., 2008; Reith et al., 2008; Kim et al., 2011; Vega-Sánchez et al., 
2014). This can result in the failure of chemotherapy for controlling disease and also 
the possible release of bioactive compounds into the aquatic environments (Giraud et 
al., 2004). Other concerns associated to the application of antimicrobial drugs are the 
limited number of antibiotics licensed for use in aquaculture, and the potential 
retention of the compounds in fish products destined for human consumption 
(Midtlyng et al., 2011; Austin & Austin, 2012; Coscelli et al., 2015). However, in the 
European Union (EU) drug residues is not important in fish now, as the Council 
Directive (EEC) no. 82/2001 provides a general withdrawal period (a period between 
treatment of food-producing animals and production of foodstuff) of 500 ℃-day for 
the depletion of residues (Esposito et al, 2007).  
 
An alternative approach is to use phage therapy as a means of biological control of 
disease. Phages can be used as therapeutic or prophylactic agents (Nakai & Park, 2002). 
However, so far, only a few attempts have been made on the experimental application 
of phages to control furunculosis (Imbeault et al., 2006; Verner-Jeffreys et al., 2007; 
Kim et al., 2015). 
1.3 Vibrios 
The vibrios are Gram-negative curved rod-shaped bacteria that are fermentative, 
catalase and oxidase positive, motile by polar flagella, usually sensitive to the 
vibriostatic agent (O/129), and mostly have a requirement for sodium chloride (Austin, 
2010). The genus Vibrio consists of more than 100 species grouped into 14 clades that 
are widespread in aquatic environments, including marine, fresh water, and estuaries 
worldwide (Romalde et al., 2013). In the last ten years, more than fifty new species 
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have been described in the genus Vibrio, attributed to the introduction of new 
molecular techniques in bacterial taxonomy, and the increasing number of 
environmental studies that have contributed to improve knowledge about vibrios and 
their phylogeny (Romalde et al., 2013). Some Vibrio spp. are important for natural 
systems, e.g. the carbon cycle (Johnson, 2013), and some are found in the natural flora 
on the surface and/or in the gastrointestinal tract of marine organisms like fish, 
shellfish, shrimp, plants, and zooplankton (Thompson et al., 2004). However, a number 
of Vibrio spp., e.g. V. anguillarum, V. harveyi and V. tapetis, are also pathogens that 
cause diseases in aquatic animals (e.g. fish, crustacea and molluscs), and some others, 
e.g. V. cholerae, V. vulnificus and V. parahaemolyticus, can infect humans (Daniels & 
Shafaie, 2000; Austin, 2010; Austin & Austin, 2012; Romalde et al., 2013). The 
epizootic bacterial diseases caused by the genus Vibrio, referred to as vibriosis, have 
brought enormous economic loss to the worldwide aquaculture industry (Liu et al., 
2013a). 
1.3.1 Vibrio splendidus 
Vibrio splendidus is a component of the normal aquatic bacterial microbiota (Lopez & 
Angulo, 1995). On the other hand, V. splendidus has been found to be a pathogen 
causing diseases in aquatic animals. Studies have reported the pathogenicity of V. 
splendidus strains associated with turbot (Scophthalmus maximus), cod larvae (Gadus 
morhua), rainbow trout and corkwing wrasse (Symphodus melops) (Angulo et al. 1994; 
Gatesoupe et al., 1999; Jensen et al., 2003; Reid et al., 2009). An aerolysin-like 
enterotoxin is an important virulence factor linked to damage of the intestinal tract 
and mortalities in cod and turbot larvae (Macpherson et al., 2012). Moreover, V. 
splendidus is an important pathogen causing massive mortality in reared molluscs, 
including oysters (Crassostrea gigas), clams (Ruditapes decussates) and Yesso scallop 
(Patinopecten yessoensis) (Gómez-León et al., 2005; Duperthuy et al., 2011; Liu et al., 
2013b). An extracellular metalloprotease (Vsm) and outer membrane protein U 
(OmpU) are the virulence factors contributing to the infections caused by V. splendidus 
in molluscs. Vsm is the major toxicity factor in the extracellular products (ECPs) 
inducing high mortality of oysters (Binesse et al., 2008). OmpU can inhibit the function 
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of antimicrobial peptides, and function as porins to attach and invade immune cells 
(Duperthuy et al., 2010; Duperhuy et al., 2011). In addition, V. splendidus is also 
associated with skin ulceration syndrome in juvenile sea cucumber (Apostichopus 
japonicus) in China (Li et al., 2010; Yan et al., 2014). 
1.3.2 Vibrio cyclitrophicus 
Vibrio cyclitrophicus can degrade and utilize polycyclic aromatic hydrocarbons (PAHs) 
(Hedlund & Staley, 2001). Based on multilocus sequence analysis (MLSA) using eight 
housekeeping genes (gapA, gyrB, ftsZ, mreB, pyrH, recA, rpoA, and topA), V. 
cyclitrophicus is grouped into the Splendidus clade of the Vibrionaceae (Sawabe et al., 
2013). Vibrio cyclitrophicus has been isolated from the haemolymph of healthy wild-
captured spider crabs (Maja brachydactyla) (Gomez-Gil et al., 2010) and reared clams 
(Ruditapes philippinarum) in Spain (Beaz-Hidalgo et al., 2008a). However, so far it has 
only been proven to be the pathogen of sea cucumber skin ulceration disease (Deng et 
al., 2009). Austin et al. (2005) considered V. cyclitrophicus to be non- or low virulent to 
rainbow trout. In addition to pathogenicity, V. cyclitrophicus enhances the total 
organic carbon (TOC) reduction rate in organically enriched sediment below fish farms, 
when co-inoculated with Capitella sp. I (Wada et al., 2008); is associated with 
biocorrosion processes in harbour zones (Boudaud et al., 2010); and also produces 
eicosapentaenoic acid (EPA) in laboratory culture conditions (Elrazak et al., 2013). 
1.4 Bacteriophages 
Bacteriophages (= phages) are a subgroup of prokaryotic viruses that specifically 
invade bacterial cells. They have been observed in great numbers and constitute the 
largest of all virus groups (Ackermann & Prangishvili, 2012). The total number of 
phages in the biosphere has been estimated at over 1030 particles (Ackermann, 2011). 
Moreover, novel phages are continually reported in investigations of the environment 
and industrial fermentations at a rate of approximately 100 per year (Ackermann, 
2007). Phages occupy all those habitats where bacteria thrive (Skurnik & Strauch, 2006; 
Wittebole et al., 2014): they occur in the oceans and fresh water, the rhizosphere, on 
plants and food, in industrial fermentations, and on the outside and in the body 
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cavities of humans and animals (Ackermann & Prangishvili, 2012). In addition, most 
cultivated bacteria harbour complete or defective prophages (Ackermann, 2007). 
However, the main habitats of phages are the oceans and topsoil (Ackermann, 2011). 
Since 1959, 6,196 phages have been examined by electron microscopy (Ackermann & 
Prangishvili, 2012). The phages belong to 10 families, and infect members of 163 
bacterial genera, most of which are the Firmicutes and γ-proteobacteria (Ackermann & 
Prangishvili, 2012). Phages are the most ubiquitous organisms on earth and play 
important roles in maintaining the natural abundance and distribution of 
microorganisms (Mathur et al., 2003; Sulakvelidze, 2011). On the level of ecosystems, 
phages can be key contributors to the mineralization of nutrients by lysing host 
bacterial cells, because they contribute to the primary ecological process of soils, 
including decomposition and decay (Allen & Abedon, 2013). In aquatic environments, 
phages potentially impact global carbon cycling by short-circuiting the movement of 
carbon and energy to heterotrophic bacteria rather than from cyanbacteria to 
consumer eukaryotes (Wilhelm & Suttle, 1999; Allen & Abedon, 2013). Phages also 
contributed as the model organisms to the development of molecular biology 
(Sulakvelidze, 2011), e.g. phages were used to identify the basis of genetic material, 
and that three nucleotides code for an amino acid (Clokie et al., 2011). 
1.4.1 Phage taxonomy 
The most important properties for phage classification are morphology, the nature of 
nucleic acid and physico-chemical properties of the virion, now increasingly 
complemented by genomic data (Ackermann, 2011). The start of phage classification 
was in 1967, when Bradley defined six basic morphotypes of phages by gross 
morphology and the type of nucleic acid, corresponding to the present phage families 
Myoviridae, Siphoviridae, Podoviridae Microviridae, Leviviridae and Inoviridae, 
respectively (Ackermann & Prangishvili, 2012). According to the VIIIth report of the 
International Committee on Taxonomy of Viruses (ICTV), phages now are classified 
into one order and 10 families (Figure 1.2) (Ackermann, 2011).  
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Over 96 % of phages are tailed and all of them belong to the order Caudovirales, which 
comprises three large phylogenetically-related families: Myoviridae, Siphoviridae and 
Podoviridae. All of the phages in the three families have icosahedral heads and double 
stranded (ds) linear DNA, but members in different families have differences in 
morphologies, specifically regarding their tails. Phages in the Myoviridae have 
contractile tails, whereas phages in Siphoviridae and Podoviridae have long non-
contractile and short tails, respectively (Ackermann, 2011). Myoviruses are often the 
most commonly isolated phages from natural marine viral communities and are 
typically lytic, having relatively broad host ranges; they tend to be larger than other 
groups and include some of the largest and most highly evolved tailed phages; their 
tails consist of a neck, a contractile sheath, and a central tube. Siphoviruses are 
frequently isolated from seawater, often have a relatively broad host range, and many 
are capable of integrating into the host genome. They are the most numerous of tailed 
phages and constitute by far the largest virus family (over 3600 descriptions, or 57.3 % 
of all viruses); their tails are simple, noncontractile, flexible or rigid tubes. Podoviruses 
are also typically lytic and have very narrow host ranges, and they are less commonly 
isolated from seawater; they may be more related to siphoviruses than to myoviruses; 
their tails are short and noncontractile (Suttle, 2005; Ackermann, 2009; Ackermann & 
Prangishvili, 2012).   
 
The remaining phages of polyhedral, filamentous or pleomorphic morphology are 
classified into 7 families separated by profound differences in nucleic acid content and 
structure. All families are small and well defined, among which both the nature of 
nucleic acid and particulars are quite varied. They contain double-stranded or single-
stranded (ss) DNA or RNA. The virions from four of the families contain lipids and two 
of them have lipoprotein envelopes (Figure 1.2) (Ackermann, 2007; 2011). 
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Figure 1.2 Overview of bacteriophage families. Adapted from Ackermann (2011). 
1.4.2 Phage replication cycles  
Phages rely on their living bacterial host cells to replicate. On the basis of the different 
relationships between phages and their bacterial hosts, there are two major life cycles: 
lytic and lysogenic, and a more sporadically way through pseudolysogeny (Fortier & 
Sekulovic, 2013) (Figure 1.3).  
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Figure 1.3 Three different life ways (lytic cycle, lysogenic cycle and pseudolysogeny) of 
bacteriophages. Adapted from Fortier & Sekulovic (2013). 
1.4.2.1 Lytic cycle 
The phages in a lytic cycle are usually termed as lytic or virulent phages. In this 
situation, phages replicate their genome and express the proteins by using host cell 
resources and energy, and producing new progeny viruses, which are released through 
host cell lysis into the environment where they can infect new bacterial cells (Almeida 
et al., 2009). The general steps in the process consist of contact, adsorption, injection 
or penetration of nucleic acid, replication and expression of the nucleic acids, virion 
assembly, release of new phage particles and transmission (Weinbauer, 2004). 
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Initially, phages adsorb to specific receptor proteins on the bacterial host surface or 
surface structures, e.g. flagella, pili, bacterial capsules and different parts of 
lipopolysaccharide (Weinbauer, 2004). Some phages may also use enzymes to 
breakdown capsule-like materials on the bacterial surface in a drill-like manner to 
reach the cell wall of the bacterium (Skurnik & Strauch, 2006). A given phage or group 
of phages can only adsorb to the particular sites on the surface of bacterial cells 
(Ackermann & DuBow, 1987). This phenomenon determines that most of the known 
phages have relatively narrow host ranges (Ackermann & DuBow, 1987). Following 
adsorption, phages use the enzymes in their tails or capsids to make the bacterial cell 
wall penetrable, and then inject their nucleic acid into the host cell cytoplasm, 
whereas the capsid remains outside the cell. In the next process, the phage genome 
directs and takes advantage of host cell resources and mechanisms to complete their 
own gene expression, genome replication, formation of capsid proteins and tails, and 
assembly of the genome and capsid into intact virions. Finally, the progeny phages are 
released from the host cell (Figure 1.3). In tailed phages, two kinds of enzymes are 
involved in the procedure of release: peptidoglycan hydrolases (endolysins) which 
break down peptidoglycan in the cell wall, and holins which permeabilize the plasma 
membrane and allow the endolysins to break down the peptidoglycan (Ackermann, 
1999; Weinbauer, 2004; Gunawardhana, 2009). The phase of a phage infection from 
adsorption to host cell lysis is termed the latent period. The phase of the latent period 
before the capsid and genome are assembled into mature phages is called the eclipse 
period. The number of virions released per cell into the extracellular environment is 
called the burst size (Abedon, 1989; Ackermann, 1999; Weinbauer, 2004).  
 
The capability to destroy bacteria is the basis of using lytic phages as therapeutic or 
prophylactic agents (Almeida et al., 2009).  However, there is a special completion of 
the lytic cycle, called chronic infection, where phages can be released by budding or 
extrusion without killing the host cells (Ackermann & DuBow, 1987; Ackermann & 
Prangishvili, 2012). The extracellular stage of all the phages ends with the deactivation 
of the phage or a new infection (Weinbauer, 2004). 
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1.4.2.2 Lysogenic cycle 
The phage in a lysogenic cycle is called a lysogenic or temperate phage. In this 
relatively dormant stage, after been injected into to the host cell, the phage genome 
integrates into a host cellular replicon, such as the chromosome, a plasmid, another 
phage genome or exists as a self-replicating plasmid. At this stage, the phage genome 
is termed a prophage. It replicates along with the host cell and is passed into daughter 
cells (Williamson et al., 2001; Dalmasso et al., 2014). Most cultivable bacterial strains 
contain inducible prophages (Ackermann & Prangishvili, 2012). According to Freifelder 
(1983), and more than 90 % of phages are temperate.  
 
A ‘lysogenic decision’, whether or not to establish a prophage state, is made after 
phage infection (Ackermann & DuBow, 1987). Prophages may spontaneously re-enter 
the lytic pathway or can be induced by a number of physical or chemical agents, such 
as UV radiation, mitomycin C, hydrogen peroxide or polyaromatic hydrocarbons 
(Williamson et al., 2001; Weinbauer, 2004), pollution, changes in temperature, salinity, 
nutrient concentration (Cochran et al., 1998; Weinbauer & Suttle, 1999; McDaniel & 
Paul, 2005) and antibiotics (Fortier & Sekulovic, 2013). The expression of lytic genes 
following damage to the host genome by any of the above mechanisms can initiate the 
lytic cycle (Williamson et al., 2001).  
 
Both phages and bacterial hosts may benefit from lysogeny. Phages benefit by using 
this approach to overcome adverse environmental and biological conditions, including 
extremes of water temperature, and the low host density during nutrient starvation. 
Conversely, lysogenic bacteria gain specific advantages from their relationship with 
phages that include expanded metabolic capabilities, antibiotic resistance, toxin 
production, and promoting bacterial evolution. The most common result is 
homoimmunity, which provides resistance to superinfection by the same or similar 
strains of phages. These effects may occur through unspecified mechanisms or the 
process of conversion, whereby prophage genes are expressed in the lysogens, or the 
bacterial host genes are modulated to express by the prophage (Williamson et al., 
2001; Fortier & Sekulovic, 2013).  
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1.4.2.3 Pseudolysogeny 
Pseudolysogeny (i.e. false lysogen or phage-carrier state) is described as a phage-host 
cell interaction in which the nucleic acid of the phage neither establishes a long-term 
and stable relationship (i.e. lysogeny) nor leads to a lytic response, but rather the 
phage nucleic acid simply resides within the cell in a non-active state (Ripp & Miller, 
1998). In this situation, the phage nucleic acid does not integrate into the host cellular 
replicons, and does not replicate and segregate into all progeny cells equally following 
host reproduction. This results in a constant production of the phage coexisting with 
high host abundance (Ackermann, 1987).  
 
Unlike lysogeny, pseudolysogeny cannot be induced to the lytic cycle by using 
chemical or physical stimulated agents (Baess, 1971; Wommack & Colwell, 2000). Ripp 
& Miller (1998) suggested that pseudolysogeny is an environmental condition in which 
starved bacterial cells coexist in an unstable relationship with infective viruses, and it is 
a legitimate strategy for environmental phages to adapt to survive periods of 
starvation of their host organisms. Under the condition, host cells cannot provide 
enough energy for the phage to initiate either a true lysogenic or lytic state. However, 
once the level of nutrient availability to the host cell increases, the phage acquires the 
necessary energy to allow gene expression, leading to either the establishment of a 
state of true lysogeny or replication and expression of the viral genome (Ripp & Miller, 
1997). This leads to virion formation and lysis of the host cell (Ripp & Miller, 1997). The 
regulation of pseudolysogeny and its effects for the host are still not well understood 
(Weinbauer, 2004). Another plausible speculation is that pseudolysogeny is a rapid 
response to environmental changes, or an evolutionary step towards the more stable 
lysogenic state (Wommack & Colwell, 2000). 
1.4.3 Vibriophages 
Vibriophages are a subset of bacteriophages, which infect bacteria belonging to the 
genus Vibrio. The start of the interest in vibriophages was due to their occurrence in 
some important human vibrio pathogens, including V. cholerae, V. vulnificus and V. 
parahaemolyticus (Gunawardhana, 2009). The first vibriophage, which was discovered 
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by d’Herelle in 1922 from stools of a patient, was a phage of V. cholerae (Chatterjee & 
Maiti, 1984).  
 
So far, vibriophages have been found in marine and fresh waters, sediments, plankton, 
molluscs, crustaceans, sewage and aquaculture environments (Ackermann et al., 1984; 
Comeau et al., 2006; Comeau & Suttle, 2007; Al-Fendi et al., 2014; Surekhamol et al., 
2014; Yingkajorn et al., 2014). According to Ackermann et al. (1984), vibriophages are 
very heterogenous and include some morphologically interesting features. For 
example, vibriophage VPI exhibits the characteristic feature of feathery collar 
appendages, VP3 has a head with spherical projections, and phage 4996 tends to form 
pairs by aggregation of tail fibres. Some vibriophages have fragile tails: upon 
contraction the tail sheaths become loose and slide along the tail tubes then finally fall 
off. By 2007, 240 vibriophages had been isolated. Most of these phages are tailed, 
belong to the families Myoviridae, Siphoviridae and Podoviridae, and possess double-
stranded linear DNA. The rest are filamentous, belonging to the family Inoviridae, and 
have single-stranded circular DNA (Ackermann, 2007). Studies on the phages of V. 
cholerae, V. parahaemolyticus, V. harveyi, V. vulnificus, V. anguillarum and V. 
alginolyticus have investigated their characterisation, classification and genome 
sequence, phage-host interaction, phage typing, prophage involvement in bacterial 
virulence as well as phage therapy (Oakey & Owens, 2000; Bhowmick et al., 2009; 
Bastias et al., 2010; Campos et al., 2010; Wei et al., 2010; Faruque & Mekalanos, 2012; 
Li et al., 2013; Nigro et al., 2012; Maina et al., 2014; Tan et al., 2014; Zhang et al., 
2014). 
1.4.4 Phages hosted by Aeromonas spp. 
Compared with vibriophages, the number of Aeromonas phages that have been 
isolated is relatively small. According to Ackermann (2007), in total 43 Aeromonas 
phages have been isolated. All of the phages are tailed, and the majority (33 phages) 
belong to the family Myoviridae, whereas only 7 and 3 phages belong to the families 
Siphoviridae and Podoviridae, respectively (Ackermann, 2007).  
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Early studies focused on phage typing, phage receptors, and the relations between 
phage sensitivity and the virulence of host cells. The majority of the work was done 
with A. salmonicida, the causal agent of furunculosis in fish, and its phages (Ishiguro et 
al., 1981; Rodgers et al., 1981; Chart et al., 1984). In contrast, current studies focus 
more on phage therapy in aquaculture (Imbeault et al., 2006; Verner-Jeffreys et al., 
2007; Jun et al., 2013). More recently, further Aeromonas phages have been isolated, 
characterised, and even complete genomes sequenced, with the purpose of choosing 
the best fit candidates against the infections caused by pathogenic Aeromonas species, 
including A. salmonicida and A. hydrophila (Kim et al., 2012a; b; c; d; Shen et al., 2012).  
1.5 Phage therapy 
Phage therapy involves using intact phages or phage enzymes (lysins) as bioagents for 
the treatment or prophylaxis of bacterial infectious diseases (Matsuzaki et al., 2005). 
This introduction will focus on therapy using intact phages. In most cases, lytic phages 
are applied in phage therapy, since they replicate quickly, and can either lyse all the 
bacterial cells or control their population to the level that the host immune system can 
clear the infection (Skurnik & Strauch, 2006; Richards, 2014). After nearly a century of 
investigation and practice, phage therapy has been increasingly used to control 
harmful bacteria in diverse fields, including human and animal health, aquaculture, 
agriculture, marine natural species recovery and the food processing industry (Nakai & 
Park, 2002; Skurnik & Strauch, 2006; Balogh et al., 2010; Cof fey et al., 2010; Kutter et 
al., 2010; Atad et al., 2012; Oliveira et al., 2012; Friedman et al., 2014). 
1.5.1 Brief history of phage therapy 
Not long after the discovery of phages in 1917, d’Herelle immediately realised their 
potential therapeutic utility as antibacterial agents, and did the first tests with animal 
models in the laboratory as well as field (Summers, 2001). He successfully used phages 
against avian typhoid in chickens, dysentery in rabbits, and haemorrhagic septicaemia 
in water buffaloes, which were caused by Salmonella gallinarum, Shigella dysenteriae 
and Pasteurella multocida, respectively (Summers, 2001). With evidence of 
therapeutic effectiveness, d'Herelle extended his phage trials to humans. The phage 
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preparations were ingested by d’Herelle and his coworkers to confirm safety, and then 
were successfully used to treat bacillary dysentery, bubonic plague, cholera and 
wound infections (Sulakvelidze et al., 2001; Summers, 2001). As a result of d’Herelle’s 
success, companies and institutions in many countries, including France, the USA, 
Poland, the former Soviet Union and India, commenced commercial production of 
phages as therapeutic agents (Sulakvelidze et al., 2001). 
 
However, following the discovery and widespread application of antibiotics in the 
1940s, together with a poor understanding of phage biology, difficulties in making 
highly purified phage preparations, and problems of setting standardisation, phage 
therapy was neglected in Western Europe and North America. However, the former 
Soviet Union and some other Eastern European countries did not stop studying phages 
for their potential therapeutic utility, and the Institute supported by Georgyi Eliava 
and d’Herelle in Tbilisi has been one of the main centres for such work (Sulakvelidze et 
al., 2001; Summers, 2001; Gross, 2011).  
 
In the 1980s, the success of a series of studies on phage treatment for E. colidiarrhea 
in calves (Smith & Huggins, 1983; Smith et al., 1987a; b) was conducted by Williams 
Smith and his colleagues in the UK, and this rekindled interest in phage therapy in the 
West. This prompted other researchers to investigate the possibility of using phages 
against antibiotic-resistant bacteria causing human infections (Sulakvelidze et al., 
2001). The majority of the following phage therapy reports in humans were from 
research groups in Eastern Europe. For example, in Poland phage therapy was 
successful in treating septicaemia, cerebrospinal meningitis in a newborn, skin 
infection and recurrent abscesses, and in the former Soviet Union during 1963-1964, 
Shigella phages administrated orally to control dysentery in 17,044 children achieved a 
2.3-fold reduction in diarrhoeal diseases compared to the placebo group (Sulakvelidze 
et al., 2001). 
 
Nowadays, many companies and universities/ institutes are working on phage therapy 
for humans and animals using current standards of clinical and microbiological 
research (Almeida et al., 2009). The phase I and II clinical trials of phage therapy for 
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chronic otitis due to antibiotic-resistant P. aeruginosa have been successfully 
completed in the UK by BioControl® Ltd. A phage product, named LMP-102 
bacteriophage preparation, consisting of a cocktail of six phages, has already been 
approved by the U.S. Food and Drug Administration to spray onto meat and poultry as 
an antimicrobial agent against Listeria monocytogenes. A Dutch food safety company, 
EBI Food Safety, has achieved GRAS (Generally Recognised as Safe) status for its 
Listeria product LISTEX™ P100, by the U.S. Department of Agriculture (USDA) and FDA. 
Other companies that are active in the development of phage products, including 
Novolytics Limited, Phico Therapeutics and Biophage Pharma Inc., are all reported to 
be developing phage products against methicillin-resistant Staphylococcus aureus 
(MRSA) and Clostridium difficile (Housby & Mann, 2009; Ryan et al., 2011; Wittebole et 
al., 2014). 
1.5.2  Phage therapy in aquaculture 
Aquaculture is the fastest-growing food-producing sector worldwide (Bostock et al., 
2010). Bacterial infections have been increasingly recognised as a significant constraint 
to aquaculture production and trade (Rao & Lalitha, 2015). Although vaccination 
seems the ideal method to prevent infectious diseases, it has been only applied in 
some fish species and to a minority of diseases with varying levels of success (Richards, 
2014). Moreover, vaccines may not be effective to the fish at their larval stages, and to 
invertebrates where a specific immune system does not exist (Carrias et al., 2012). 
Antibiotic treatment is a rapid and effective method to treat bacterial infection, but 
long-term and frequent usage has resulted in an increasing frequency of drug-resistant 
bacterial strains and ineffectiveness of such treatments (Pereira et al., 2011; Richards, 
2014). Moreover, the toxicity and residues of antibiotics in aquatic food products and 
the surrounding environment is another severe drawback for use (Oliveira et al., 2012). 
Now in the UK only three antibiotics are licensed for use in fish farming 
(http://www.gov.scot/Resource/0040/00408269.pdf), which means the choices of 
antibiotics for fish farmers to access are very limited. Therefore, it is urgent to develop 
safer and more environmental-friendly methods to control bacterial infections in 
aquaculture. 
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Using lytic phages, i.e. phage therapy, as bioagents for the treatment or prophylaxis of 
bacterial infectious diseases is one of the particularly promising approaches. The first 
attempt at using phage therapy was reported in 1981 from Taiwan by Wu and 
colleagues, who found the loss of pathogenicity of A. hydrophila to loach (Misgurnus 
anguillicaudatus), when the pathogen was infected by phage Ah1 before it was 
injected into the fish (Wu et al., 1981). Then in the late 1990s, a Japanese research 
group successfully used phages to treat Lactococcus garvieae infection in yellowtail 
(Seriola quinqueradiata) (Park et al., 1997; 1998; Nakai et al., 1999) and P. 
plecoglossicida infection in ayu (Plecoglossus altivelis) (Park et al., 2000; Park & Nakai, 
2003). Nowadays, research work related with the application of phage therapy against 
bacterial infections in aquaculture has been conducted worldwide, and has involved 
more bacterial pathogens and aquaculture animals (Table 1.1). In addition, using 
phages against bacterial contamination has been investigated in the processing of 
aquaculture food products (Jun et al., 2014; Rong et al., 2014). However, there is a 
possibility of ‘negative’ study results not being published thus leading to a publication 
bias of ‘positive’ results. Studies also have examined phage dispersal and survival in 
animals and in the environment, the ecological effects on bacterial community 
structure, and have developed guidelines for use in fish and shellfish (Pereira et al., 
2011; Madsen et al., 2013; Richards, 2014).   
1.5.3 Advantages and limitations of phage therapy 
Compared with antibiotic treatments, phage therapy has a number of advantages. 
 
Phages are usually highly specific to a single species or strain of bacteria. Therefore, 
phage therapy will only cause minimal disruption to the normal intestinal flora in 
animals, and exert low impact on the natural microflora (Loc-Carrillo & Abedon, 2011). 
In contrast, many antibiotics have broad spectra activity, which leads to non-specific 
killing of both pathogens and members of the normal flora (Loc-Carrillo & Abedon, 
2011). This results in the potential for altering the composition of the natural flora, 
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and could lead to secondary or superinfections (Loc-Carrillo & Abedon, 2011; Golkar et 
al., 2014). 
  
Phage therapy is considered safer than antibiotics as no serious complications have 
been reported during or after phage treatments in humans (Sulakvelidze et al., 2001). 
However, some mild side effects (e.g. fever) have occasionally been reported due to 
the release of endotoxins from bacteria when they are lysed by phages inside the 
human body (Gunawardhana, 2009). In contrast, antibiotic treatments often cause 
side effects, including intestinal disorders, allergies (sometimes even fatal) and 
secondary infections (Sulakvelidze et al., 2001; Gunawardhana, 2009; Golkar et al., 
2014).  
 
Phages replicate and multiply in the environment where host bacteria are present. 
Moreover, phages are self-replicating as well as self-limiting. They replicate 
exponentially as bacterial numbers increase, may decline when bacteria number 
decreases, and finally may be at undetactablely low numbers after the host bacteria 
are removed (Almeida et al., 2009).  Thus, only small and less frequent phage doses 
may effectively kill the targeted pathogens at the site of infection, and will not 
continue to persist after treatment. Although antibiotics can be metabolised and 
eliminated, it is still possible that the residue can accumulate in tissues (Skurnik et al., 
2007). Moreover, antibiotics travel throughout the body and cannot concentrate at 
the infection site. To compensate for the loss in other parts of the body, high 
concentrations and repeated doses of antibiotic are needed (Sulakvelidze et al., 2001; 
Summers, 2001; Skurnik et al., 2007; Golkar et al., 2014).  
 
Bacteria can develop resistance to phages during the period of phage therapy, but it is 
usually possible to select and purify a new phage having lytic activity against the 
phage-resistant bacterial mutants within a few days or weeks. This is because phages 
are co-evolving with their host bacteria, and outnumber bacteria in the environment 
tenfold (Morrison & Rainnie, 2004; Almeida et al., 2009). In contrast, development of a 
new antibiotic is usually very time-consuming and expensive in demonstrating safety 
and efficacy and conforming to quality standards (Huys et al., 2013; Golkar et al., 
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2014). Using engineered phages or phage enzymes, or a cocktail of phages with 
different bacterial receptors may overcome the problems of resistance (Golkar et al., 
2014; Viertel et al., 2014). Moreover, phage-resistant bacteria can have reduced or 
lost virulence, because the receptors used by some phages to attach to bacteria may 
be associated with virulence (Smith & Huggins, 1983; Skurnik & Strauch, 2006; 
Capparelli et al., 2010a). 
 
However, there are some limitations that should be considered before using phage 
therapy: 
The specificity and narrow host ranges of phages makes it difficult to use the viruses 
against highly diverse bacterial variants. In this situation, before carrying out phage 
therapy, the nature of the pathogen and confirmation of phage susceptibility are 
required. However, use of a mixture of phages, i.e. phage cocktails, can overcome this 
limitation (Sulakvelidze et al., 2001; Loc-Carrillo & Abedon, 2011; Lu & Koeris, 2011).  
 
Phage particles may be rapidly cleared from the body by host defence systems, 
including neutralisation by antibodies (Almeida et al., 2009) leading to a reduction in 
the number of phages available at the infection sites (Merril et al., 1996). These 
problems may be resolved by selecting phage mutants that are able to remain in the 
circulatory system (Merril et al., 1996) or giving repeated administration of the same 
phage to the organism (Barrow & Soothill, 1997).  
 
Some lytic as well as temperate phages may act as vectors for transferring genes to 
bacteria, which can confer resistance to antibiotics and encode virulence (Almeida et 
al., 2009). This may result in enhanced virulence and transformation of non-
pathogenic to pathogenic strains (Almeida et al., 2009). Careful screening of suitable 
phages, sequencing of phage genomes to avoid transmission of virulence genes, and 
construction of genetically modified mutant phages are all possible methods to 
address this issue (Matsuzaki et al., 2005; Skurnik & Srauch, 2006; Loc-Carrillo & 
Abedon, 2011). 
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Table 1.1 Studies of phage therapy in disease control in aquaculture. 
Pathogen Disease Animal Phage 
Administration 
Treatment  effective Success 
Aeromonas hydrophila Haemorrhagic 
septicaemia  
Cyprinid loach 
(Misgurnus 
anguillicaudatus) 
I.p.; oral Both of the i.p. and oral administration 
improved the survival of the phage-
treated loaches (Jun et al., 2013). 
Yes 
A. salmonicida Furunculosis  Rainbow trout 
(Oncorhynchus mykiss) 
I.m. Phage treatment with a MOI of 10,000 
showed notable protective effects with 
increased survival rates and mean times to 
death (Kim et al., 2015). 
Yes 
 Furunculosis Atlantic salmon (Salmo 
salar) and rainbow 
trout (Oncorhynchus 
mykiss) 
I.p.; oral; bath No adverse effect was observed. However, 
using a combination of three phages by 
i.p. injection only delayed the death, but 
didn’t affect the end result. No protection 
was offered by any of the phage 
treatments (i.p., oral or bath) (Verner-
Jeffreys et al., 2007). 
No 
 Furunculosis Brook trout (Salvelinus 
fontinalis) 
Water-borne Delayed the onset of infection in fish by 7 
days (Imbeault et al., 2006). 
Yes 
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Edwardsiella ictaluri Edwardsiellosis Ayu (Plecoglossus 
altivelis) 
I.p. Higher protection was observed in fish 
that were first injected with phages and 
then 1 hour later injected with the 
pathogen, whereas the fish that were first 
injected with the pathogen and then the 
phages only showed delayed mortality 
compared with the control (Mahmoud & 
Nakai, 2012). 
Yes 
Flavobacterium 
columnare 
Columnaris 
disease 
Catfish (Clarias 
batrachus) 
I.m.; bath; oral Phage treatment led to disappearance of 
gross clinical signs, negative 
bacteriological test, detectable phage and 
100 % survival in experimentally infected 
fish (Prasad et al., 2011). 
Yes 
F. psychrophilum Cold water 
disease  
Atlantic salmon (Salmo 
salar) and rainbow 
trout (Oncorhynchus 
mykiss) 
I.p. Mortality decreased when phages were 
present (Castillo et al., 2012). 
Yes 
Lactococcus garvieae Lactococcosis  Yellowtail (Seriola 
quinqueradiata) 
I.p.; oral Both i.p. and orally administered phage 
prevented fish from experimental L. 
garvieae infection (Nakai et al., 1999). 
Yes 
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Pseudomonas 
aeruginosa 
Ulcerative 
lesions  
Catfish (Clarias 
gariepinus) 
On-spot 
treatment 
Phage therapy effectively cured the 
ulcerative lesions of the infected fish in 8-
10 days of treatment, with a sevenfold 
reduction of the lesion with untreated 
infection control (Khairnar et al., 2013). 
Yes 
P. plecoglossicida Bacterial 
haemorrhagic 
ascites disease 
Ayu (Plecoglossus 
altivelis) 
Oral Phage-receiving fish showed high 
protection against infection with the 
pathogen (Park & Nakai, 2003). 
Yes 
Streptococcus iniae Streptococcosis  Japanese flounder 
(Paralichthys olivaceus) 
I.p. Mortalities of fish receiving phages were 
significantly lower than the control fish 
without phage-treatment (Matsuoka et 
al., 2007). 
Yes 
Vibrio alginolyticus Skin ulceration 
and viscera 
ejection 
Sea cucumber 
(Apostichopus 
japonicus) 
Immersion Phage treatment increased the survival of 
sea cucumbers to 73, 50 and 47 % when it 
was used with a MOI of 10, 1 or 0.1, 
respectively, whereas the no phage 
treatment group only had 3 % survival 
(Zhang et al., 2015). 
Yes 
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V. anguillarum Vibriosis  Atlantic salmon (Salmo 
salar) 
Water-borne Phage treatment increased the survival of 
fish to 100 % when it was used with a MOI 
of 1 and 20, versus less than 10 % of 
survival in the absence of the phage 
(Higuera et al., 2013). 
Yes 
V. harveyi Luminous 
vibriosis 
Shrimp (Penaeus 
monodon) 
Immersion Phage therapy clearly improved shrimp 
larval survival in the presence of the 
pathogen (Karunasagar et al., 2005; 2007) 
Yes 
V. parahaemolyticus Vibriosis Whiteleg shrimp 
(Litopenaeus 
vannamei) larvae 
Immersion MOI = 0.1 was enough to counteract the 
infection, and an early application (at 6 
hours post-infection) was effective to 
avoid mortality (Lomelí-Ortega & 
Martínez-Díaz, 2014).  
Yes 
 Vibriosis Brine shrimp (Artemia 
franciscana) 
 A single dosage of the phage was effective 
to eliminate the adverse effects of the 
pathogen. However, when the phage 
treatment was delayed, it was ineffective 
to control the mortality (Martínez-Díaz & 
Hipólito-Morales, 2013). 
Yes 
MOI: multiplicity of infection; i.p.: intraperitoneal; i.m.: intramuscular. 
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1.6 Study Aims  
The aims of this research were: 
1. To develop the methods for isolation, identification and characterisation of lytic 
vibriophages and their Vibrio hosts, and evaluate the potential for setting up 
phage therapy models by using these vibriophages and their hosts (Chapter 2). 
2. To isolate and characterise lytic A. salmonicida phages from the fresh water 
aquaculture environment, and investigate the effect of these phages on A. 
salmonicida growth in vitro as well as estimate the efficiency of phage therapy 
against A. salmonicida infections in a rainbow trout model (Chapter 3). 
3. To estimate the risk of phage-resistant bacterial mutants generated during the 
process of phage therapy against A. salmonicida infections, by inducing phage-
resistant mutants of A. salmonicida in vitro and comparing the physicochemical 
characteristics and virulence with that of the wild-type strain (Chapter 4). 
4. To discuss the prospects for application of phages in aquaculture (Chapter 5). 
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Isolation, Identification and Characterisation of Two 
Lytic Vibriophages and Their Hosts from the 
Aquaculture Environment 
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2.1 Introduction 
Vibrios are ubiquitous and abundant in aquatic environments including marine, fresh 
water, and estuaries, worldwide. The genus Vibrio consists of more than 100 species 
grouped into 14 clades (Romalde et al., 2013). Most Vibrio spp. are a likely component 
of the normal aquatic bacterial micro biota contributing to the carbon cycle (Johnson, 
2013), and some are the natural flora on the surface and/or in the gastrointestinal 
tract of marine organisms such as fish, shellfish, shrimps, plants, and zooplankton 
(Thompson et al., 2004). However, a number of Vibrio spp., e.g. V. anguilarum, V. 
salmonicida (= Aliivibrio salmonicida), V. harveyi and V. tapetis, are bacterial 
pathogens that cause diseases in aquatic animals (e.g. fish, crustaceans and molluscs) 
(Daniels & Shafaie, 2000; Austin, 2010; Austin & Austin, 2012; Romalde et al., 2013). 
The epizootic bacterial diseases caused by the genus Vibrio, named vibriosis, have 
brought enormous economic loss to the worldwide aquaculture industry (Liu et al., 
2013a); vibriosis can occur suddenly and sometimes leads to the death of the entire 
infected population (Thompson et al., 2004). 
 
Vibriophages are a subset of bacteriophages, which occupy all those habitats where 
vibrios thrive. So far, vibriophages have been found in marine and fresh waters, 
sediments, plankton, molluscs, crustaceans, sewage and aquaculture environments 
(Ackermann et al., 1984; Comeau et al., 2006; Comeau & Suttle, 2007; Al-Fendi et al., 
2014; Surekhamol et al., 2014; Yingkajorn et al., 2014). Studies on the phages of V. 
cholerae, V. parahaemolyticus, V. harveyi, V. vulnificus, V. anguillarum and V. 
alginolyticus have included their characterisation, classification and genome sequence, 
phage-host interaction, phage typing, prophage involvement in bacterial virulence, as 
well as phage therapy (Oakey & Owens, 2000; Bhowmick et al., 2009; Bastias et al., 
2010; Campos et al., 2010; Li et al., 2013; Nigro et al., 2012; Tan et al., 2014; Zhang et 
al., 2014). 
 
In this study, lytic vibriophages were isolated along with their Vibrio hosts from a same 
marine fish farm environmental sample. The study aimed to: (i) develop methods for 
the isolation of lytic vibriophages and their bacterial hosts from the same sample; (ii) 
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identify and characterise the phages and their hosts; (iii) investigate the pathogenicity 
of the Vibrio hosts using different in vivo models; and (iv) evaluate the potential for 
setting up phage therapy models by using these vibriophages and their hosts. 
2.2 Materials and methods 
All the media and chemicals were purchased from Oxoid (Basingstoke, UK), and Sigma-
Aldrich (Basingstoke, UK), respectively, unless otherwise stated. 
2.2.1 Sample collection and processing 
A mixed sample (100 mL) of water and sediment was collected using a 250 mL sterile 
laboratory capped bottle (Fisherbrand, UK) from the outlet pond of a Scottish marine 
fish farm in May 2011. The water temperature and salinity were 12 ℃ and 30 ‰, 
respectively.  
 
The sample was blended using a sterile wooden stick for 10 min, and then incubated at 
15 ℃ for 3 hours to allow free bacteria and phages to move into the liquid component. 
During the incubation period, the mixed sample was inverted frequently to increase 
the disruption of particulate material to distribute the bacteria and phages throughout 
the water and sediment mixture. After incubation, the sample was transferred into 
sterile 50 mL centrifuge tubes (VWR, UK) and centrifuged at 1,000 x g, 4 ℃ for 5 min 
(Sigma 4K15C centrifuge) to precipitate the sediment particles. The supernatant was 
then carefully pipetted into sterile tubes and stored at 15 ℃. 
2.2.2 Isolation of Vibrio spp.  
The supernatant from above was diluted in sterile 3 % (w/v) NaCl to 10-1, 10-2 and 10-3, 
before 100 μL volumes were spread evenly over thiosulphate citrate bile salts sucrose 
agar plates, supplemented with 3 % (w/v) NaCl (TCBS+N) plate, in triplicate. After 
drying for 15 min on the bench, the plates were sealed with parafilm and incubated at 
15 ℃ for 7 days and checked for bacterial growth. 
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Single colonies of bacteria were picked according to their colony morphology (colour, 
shape, size) and sub-cultured several times on TCBS+N plates to obtain purified 
cultures, which then were numbered and preserved at - 70 ℃ using microorganism 
preservation beads (Technical Service Consultant Ltd, UK).  
2.2.3 Enrichment and isolation of vibriophages 
The method of enrichment was modified from Van Twest & Kropinski (2009). Ten 
millilitres of supernatant (obtained from Section 2.2.1) was mixed well with the same 
volume of double-strength tryptone soya broth (TSB; Oxoid)  supplemented with 3 % 
(w/v) NaCl (TNB), and incubated in a Kuhner shaker (ISF-1-W, Switzerland) at 15 ℃, 
140 rpm for 24 hours, aiming for phage enrichment. After incubation, 0.5 mL of 
chloroform was added into the tube, which was then inverted for 10 min, to disrupt 
the bacterial cells and release any phages. After centrifugation at 4,000 x g, at 4 ℃ for 
15 min, the supernatant was carefully transferred; filter sterilised by passage through 
0. 20 μm low protein binding membrane (cellulose acetate) filters (Minisart®, Sartorius 
Stedim, UK), and stored at 4 ℃. 
 
The double agar overlay plaque assay of Kropinski et al. (2009) was used for phage 
isolation, with minor variations. The top agar was made of TNB supplemented with 
0.3 % (w/v) agar, and kept in a water bath at 30 ℃ after being sterilized. The bottom 
agar was made of tryptone soya agar (TSA, Oxoid) with 3 % (w/v) NaCl (TNA), and ~15 
mL was poured into each 90 mm diameter sterile plastic petri dish to form the 
underlay base. The bacteria that were isolated (from Section 2.2.2) were used as the 
potential hosts for phage isolation. For each bacterial isolate, 200 μL of an overnight 
broth culture was mixed with 200 μL of the phage suspension in a sterile bijoux bottle. 
The mixture was incubated at room temperature (~22 ℃) for 5-10 min to allow the 
phages to adsorb the host cells. Five milliliters of the molten, cooled to 30 ℃ top agar 
were added into the bijoux, which then was inverted 5 times and immediately poured 
over the solid layer of medium in a petri dish. Then the plate was left standing for 15 
min to form a thin overlay. In total, 1 mL of the phage suspension was plated (into 5 
plates) for each bacterial isolate. The plates that were only plated with each bacterial 
isolate, but no phage suspension, were used as the blank control for plaque 
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examination. All the plates were incubated at 15 ℃ for 24 hours, and examined for the 
presence of plaques in the bacterial lawn. The plaques were indicative of the presence 
of lytic phages.  
 
On the basis of plaque size and morphology, single plaques were picked with sterilised 
pipette tips or Pasteur pipettes and transferred into bijoux bottles containing 5 mL 
volumes of phage salt-magnesium (SM) buffer (50 mM Tris-HCl, pH 7.5; 100 mM NaCl; 
8.1 mM MgSO4·7H2O and 0.01 % gelatin) and inverted several times. A serial dilution 
(100, 10-1 and 10-2) was made for each phage suspension, and a 10 μL volume of each 
dilution was plated with the same bacterial isolate (used as the indicator bacterium in 
the subsequent experiments) from which the plaque had been acquired, using the 
double agar overlay plaque assay described above. This procedure was repeated at 
least three times to ensure the purity of each phage. The phage suspension from the 
final purification was filter sterilised by passing through a sterile 0. 20 μm filter, and 
used for the subsequent experiments.  
 
For phage propagation and also the preparation of phage stock, a liquid broth method 
adapted from Fortier & Moineau (2009) was used. A 10 μL volume of the purified 
phage suspension was inoculated into 10 mL of the indicator culture in TNB with an 
OD600 of 0.10 to 0.20, and incubated with shaking at 15 ℃, 140 rpm overnight. The 
phage suspension was harvested by centrifugation and filtration, as before. For long-
term storage, the resulting phage suspension was mixed well with an equal volume of 
glycerol to obtain a final concentration of 50 % (Ackermann et al., 2004) and stored at 
- 70 ℃. For short-term storage, the filtered phage suspension was stored at 4 ℃ 
without glycerol supplementation. The titre of each filtered phage suspension was 
determined using the double agar overlay plaque assay. 
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2.2.4 Identification and characterisation of the bacterial hosts 
2.2.4.1 Conventional tests 
The conventional bacterial identification tests used in this study included Gram stain, 
motility, oxidase, oxidation/fermentation (O/F), O/129 (10 and 150 μg), were 
performed following routine procedures (Frerichs & Miller, 1993). The biochemical 
profiles were determined using the API 20E rapid identification system (BioMerieux, 
Basingstoke, UK) and following the manufacturer’s instructions. The incubations for 
O/F and API 20E assays were performed at 15 ℃, and the readings were recorded 
every 24 hours for 3 days.  
2.2.4.2 Identification by 16S ribosomal RNA gene sequencing 
Bacterial DNA was extracted following a boiling lysis method which was adapted from 
Queipo-Ortuno et al. (2008). The bacterial overnight broth culture was pelleted by 
centrifugation at 12,000 x g for 2 min, and then washed once in sterile 3 % (w/v) NaCl. 
The bacterial pellet was resuspended in molecular biology-grade water (Milli-Q®), 
heated at 95 ℃ for 10 min, followed by immediately cooled on ice, and centrifuged at 
13,000 x g for 1 min to remove bacterial debris. The supernatant containing bacterial 
DNA was stored long-term at - 20 ℃ or at 4 ℃ for immediate analysis by Polymerase 
Chain Reaction (PCR). 
 
The primer set 20F (5’-AGAGTTTGATCCTGGCTCAG-3’; equivalent to positions 8-27 in 
Escherichia coli 16S rRNA gene) and 1500R (5’-GGTTACCTTGTTACGACTT-3’; equivalent 
to positions 1510-1492 in E. coli 16S rRNA gene) were used for the amplification of the 
16S rRNA gene from genomic DNA of the bacterial isolates (Weisburg et al., 1991). The 
PCR amplification was carried out in a total volume of 50 μL, containing 25 μL of PCR 
Master Mix (Thermo Scientific, UK), 10 pmol of each primer, 50 ng of template DNA, 
and nuclease-free water to volume. The genomic DNA template was substituted with 
nuclease-free water or E. coli genomic DNA for negative or positive control, 
respectively. The PCR reaction was performed in a GeneAmp PCR System 9700 thermal 
cycler (ABI, USA), and consisted of an initial denaturation at 95 ℃ for 2 min followed 
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by 30 cycles of denaturation at 95 ℃ for 1 min, annealing at 54 ℃ for 1 min, and 
extension at 72 ℃ for 1.5 min. Then, the reaction was completed by extension at 72 ℃ 
for additional 5 min. The resulting PCR amplicons were examined by electrophoresed 
on 1.2 % agarose (Invitrogen, UK) gel containing 0.5 μg mL-1 ethidium bromide at 80 V 
for 1 hour, and visualised under UV light using a trans illuminator (Syngene, 
BioImaging, UK). The expected size of the PCR products was approximately 1500 bp.   
 
The amplified products were purified using a QIA quick Kit (Qiagen, UK) following the 
manufacturer’s protocol. The purified PCR products were sequenced at the University 
of Dundee (The Genetics Core Services Unit, School of Medicine) using a ABI 3730 DNA 
sequencer with the amplification primer set 20F and 1500R. The obtained partial 16S 
rRNA gene sequences were analysed using the Basic Local Alignment Search Tool 
(BLAST) algorithm at the National Centre for Biotechnology Information 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
2.2.4.3 Phylogenetic analysis 
A phylogenetic tree was constructed based on the 16S rRNA gene sequences of the 
isolated bacterial strains, 15 other Vibrio spp. strains from Splendidus clade, one V. 
harveyi strain and one V. campbellii strain (used as a outgroup) by the neighbour-
joining (N-J) algorithm using the MEGA 4.1 software.  
2.2.4.4 Morphology observation by Transmission Electron Microscopy 
A drop of dense bacterial suspension in 3 % (w/v) NaCl was deposited on a 200 square 
mesh Formvar-coated copper grid for 1 min at room temperature. Excess liquid was 
drained off using a filter paper, and a drop of 2 % phosphotungstic acid (pH 7.2; 
EMscope) was added as stain for 1 min. Excess stain was blotted, and the grid was air 
dried, followed by examined under an FEI Tecnai Spirit GR Biotwin Transmission 
Electron Microscope (TEM).  
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2.2.4.5 Temperature and salinity range for growth 
Single colonies were either streaked onto TNA plates which were incubated at 4 ℃, 
15 ℃, 22 ℃, 28 ℃, 30 ℃ and 37 ℃, or inoculated in 5 mL of TSB with different NaCl 
concentrations of 0.5, 1, 2, 3, 4, 5, 6, 7, 8 and 9 % and incubated at 15 ℃. The 
observation for bacterial growth were recorded every 24 hours for 7 days. 
2.2.4.6 Extracellular enzymatic activity 
To determine the production of extracellular enzymes, the bacterial cultures were 
inoculated onto TNA plates which were supplemented with the following substrates: 
5 % (w/v) skimmed milk (Marvel) for protease, 5 % (v/v) sheep blood (Oxoid) for 
haemolysin, 1 % (v/v) Tween 80 (Sigma Aldrich) for lipase and 0.1 % (w/v) gelatin 
(Oxoid) for gelatinase, respectively. The plates were then incubated at 15 ℃ for 3-5 
days. The positive results for protease, haemolysin and gelatin (following the addition 
of saturated ammonium sulphate) showed clear zones around the bacterial colonies, 
whereas for lipase positive a zone of precipitation of salts of fatty acids shows around 
the bacterial colony.  
2.2.4.7 Detection of virulence genes  
According to the gene sequences of pathogenic V. splendidus strain LGP32 (Le Roux et 
al., 2009), two primer sets were designed to detect the genes of two virulence factors 
from the genome DNA of isolate V9, respectively: V-vsmF (5’-CCAACAGAGCCTCGTCG-
3’; equivalent to positions 111-127 in V. splendidus vsm gene) and V-vsmR (5’-
TGCTTTAGCGTGGTTTAGT-3’; equivalent to positions 594-576 in V. splendidus vsm 
gene) for the metalloprotease gene vsm, V-ompuF (5’-TGCTACTGGTGCTAACG-3’; 
equivalent to positions 45-61 in V. splendidus ompU gene) and V-ompuR (5’-
TCACCGAATGTACCGC-3’; equivalent to positions 329-314 in V. splendidus ompU gene) 
for the outer membrane protein gene ompU. The PCRs were performed using the 
same annealing temperature 49 ℃. The type strain V. splendidus NCIMB 1T was used 
as the positive control. The PCR products were detected by electrophoresis, and then 
purified and sequenced with the same method as described above. 
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2.2.5 Pathogenicity of host bacteria 
2.2.5.1 Passages in rainbow trout (Oncorhynchus mykiss) 
Prior to performing the challenge studies, to enhance virulence, the Vibrio strains were 
passaged through healthy fish three times by intraperitoneal (i.p.) injection with a high 
bacterial concentration as per standard practice at the Institute of Aquaculture, 
University of Stirling. The bacteria strain was inoculated onto 5 % (v/v) sheep blood 
agar, and then a single colony was aseptically picked and cultured in broth overnight (~ 
18 h). The bacterial suspension was centrifuged, washed once, and re-suspended in 
0.5 mL sterile 0.85 % saline to get a high bacterial concentration (> 109 CFU mL-1). One 
hundred microlitres of this bacterial suspension was injected by intraperitoneal (i.p.) 
into a healthy rainbow trout in the size of ~ 18 g. The bacteria were recovered from 
the anterior kidney and spleen of the moribund or dead fish by direct plating of the 
organ onto agar. If morbidity or mortality did not happen, the fish were sacrificed on 
the second day post injection, and sampled for bacterial recovery. This passage was 
repeated twice, and the isolate recovered from the 3rd passage was purified and 
confirmed the identity using the methods described above. Then the bacterial strain 
was ready for the challenge studies. If a bacterial strain did not result in the passage 
fish becoming moribund or dead in all the three passages then this strain was 
considered to be not pathogenic to rainbow trout, and would not be used in the 
challenge studies.   
 
All the fish challenge experiments were carried out in the Aquatic Research Facility 
(ARF), University of Stirling. Fish were kept in the tanks with a continuous flow-through 
water system, except for the goldsinny wrasse challenge, where the fish were kept in 
3.5 % artificial sea water with 80 % water changed every two days. In all the fish 
challenges, water temperature was controlled at 15 ℃ ± 2 ℃ with a 12 hours light : 12 
hours dark cycle and aeration applied. The experimental fish were fed with 
commercial diets once daily. 
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2.2.5.2 Challenge study in rainbow trout  
The bacterial inoculum for challenges was prepared as follows using the ex-passage 
strains: A single colony was inoculated into 20 mL of TNB, and cultured for 18 hours at 
140 rpm, 22 ℃. The culture was then centrifuged at 3,500 × g for 20 min at 4 ℃, and 
washed once using 0.85 % sterile saline. The pellet was finally re-suspended and 
adjusted using sterile 0.85 % saline to get OD600 = 1.0, which gave approximately 10
8 
CFU mL-1. Then 10-fold serial dilutions were performed to get the aimed 
concentrations for injections. The actual concentrations of the injected bacterial 
preparations were calculated using Miles & Misra viable bacterial colony count 
method (Miles et al., 1938).  
 
This challenge used two groups of 5 fish per group. One group was challenged by i.p. 
injection with a bacterial concentration of 107 CFU fish-1 approximately. The other 
group was injected in the same way but with sterile 0.85 % saline as the control. The 
fish were kept for 21 days, and checked four times daily for any gross clinical signs of 
disease, and morbidity/mortality.  
 
Any dead or moribund fish were removed from the tanks, but only freshly dead, 
moribund fish and 50 % of the survivors from each group were sampled for bacterial 
recovery and histopathology. The sampled fish were first examined for external and 
internal clinical signs of disease as observed grossly. Anterior kidney and spleen were 
sampled for bacteria by inserting a sterile loop into the organs and streaking onto TNA 
plates, which then were sealed with parafilm and incubated at 15 ℃. The plates were 
kept for one week, and checked for bacterial growth and purity. Organs, including gills, 
brain, spleen, liver, heart, kidney, intestine and muscle with any lesions were fixed in 
10 % neutral buffered formalin (NBF) for histopathology tests.     
2.2.5.3 Challenge study in goldsinny wrasse (Ctenolabrus rupestris)  
According to Austin et al. (2005), different administration methods of bacteria in 
challenge can affect the virulence of bacterial pathogens, and cause different clinical 
signs. Thus, in the challenge using goldsinny wrasse, both intraperitoneal and 
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intramuscular injections were applied. Eighteen goldsinny wrasse (2-3 g) from a 
Scottish marine fish farm were randomly put into 6 groups of 3 fish per group. Three 
groups were injected with the bacterial preparations of V9, V13 and sterile 0.85 % 
saline by i.p., respectively. The other three groups were injected with the same 
preparations, but by intramuscular (i.m.) below the dorsal fin. Groups were injected 
with sterile 0.85 % saline as the controls for i.p. and i.m. injection, respectively (Table 
2.1). The bacterial preparations were prepared as described above, aiming to give 106 
CFU fish-1. This dose was lower than the one used in the rainbow trout challenge study, 
as the wrasse were much smaller in size than the rainbow trout  
 
The fish were kept for 14 days, and checked for any morbidity/mortality, gross clinical 
signs of disease, and inflammation or lesions around the injection site. Because the 
fish were small, they were only sampled and examined external and internal clinical 
signs of disease, and bacterial recovery by inserting a sterile loop into the abdominal 
cavity and streaking onto TNA plates. These were incubated at 15 ℃ for one week, and 
checked for bacterial growth and purity. 
Table 2.1 Experimental design of the challenge study in goldsinny wrasse. 
Group No. Treatment No. of fish 
1 i.p. with sterile 0.85 % saline 3 
2 i.p. with V9 preparation 3 
3 i.p. with V13 preparation 3 
4 i.m. with sterile 0.85 % saline 3 
5 i.m. with V9 preparation 3 
6 i.m. with V13 preparation 3 
i.p. = intraperitoneal, i.m. = intramuscular, % = percentage.  
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2.2.5.4 Challenge study in Artemia (brine shrimp) nauplii model 
Disease-free Artemia cysts (Waterlife, Longford, UK) were hatched in sterile artificial 
seawater (salinity = 25 ‰) at 28 ℃ with constant aeration (fine bubble air stone) and 
fluorescent light for 24 hours. An overnight culture of the bacterial isolates were 
pelleted by centrifugation at 3,500 × g, washed once and adjusted to a concentration ~ 
107 CFU mL-1 for infection using the same sterile artificial seawater for Artemia 
hatching. The reason for using the bacterial concentration of 107 CFU mL-1 for infection 
was that the concentration of 106 CFU mL-1 was used as the highest dose by the 
researchers in their studies of estimating the pathogenicity of vibrios to Artemia 
nauplii (Soto-Rodriguez et al., 2003; Austin et al., 2005; Defoirdt et al., 2007), so that a 
higher dose, i.e. 107 CFU mL-1, was chosen for this study. Hatched Artemia nauplii were 
transferred to 20 mL of sterile artificial seawater, V9 inoculum and V13 inoculum, 
respectively, with 50 nauplii in each group. Nauplii were mixed well with bacteria for 5 
min and then one Artemia nauplii was transferred with 250 μL of the according 
inoculum, using sterile filter pipettes, to one well on a 96-well flat-bottom plate 
(Sarstedt, UK). The 96-well plates were sealed and incubated at 22 ℃ for 3 days, and 
the survival was recorded every 24 hours. Artemia nauplii in sterile artificial seawater 
without adding bacteria were used as the control.  
2.2.6 Characteristics of the vibriophages 
2.2.6.1 Morphology observation by TEM 
The filtered propagated phage suspension was used for morphology observation by 
TEM following negative staining method (Ackermann, 2009a). Briefly, phage 
suspension was purified by washing with 0.1 M ammonium acetate (pH 7) three times 
using a centrifuge (IEC Micromax, US) at 25,000 x g, 60 min each time. In the staining 
processes, 10 μL of the purified phage sample was added onto a 200 square mesh 
Formvar-coated copper grid, after 1 min adsorption, the excess liquid was drained off 
with filter paper before 10 μL of 2 % phosphotungstate (pH 7.2) added onto the grid to 
stain for 1 min. Excess liquid was drained off with filter paper again, and the grid was 
finally air dried instantly. The grids with stained phage samples were observed under a 
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Philips (FEI) CM120 Biotwin Transmission Electron Microscope (TEM). The diameters of 
the phage heads and the lengths of the tails were determined based on the 
measurments from 5 phages.  
2.2.6.2 Host range test  
In the phage host range test, 39 Vibrio strains which were either from the laboratory 
collection, or purchased from the National Collection of Industrial, Marine and Food 
Bacteria (NCIMB), and 12 unidentified bacterial strains (isolated in 2.2.2) were used 
(Table 2.2). The spot test method from Ra’l & H’bert (2009) was followed. Briefly, 200 
μL of an overnight culture of the test bacterial strain was mixed with 5 mL of the 
molten top agar, and then poured to a plate containing bottom agar. After the top 
agar solidified, 10 μL of each sterile propagated phage supernatant was spotted over 
the top layer, and allowed to absorb. All the plates were incubated at 22 ℃ overnight. 
The original phage bacterial hosts were used as the positive control for bacterial 
strains, and sterile phage SM buffer was used as the negative control for phages. The 
formation of plaques was checked on the following day. The experiment was repeated 
twice. 
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Table 2.2 Vibrio spp. strains used for phage host range test. 
Identification Collection Number Source  
V. splendidus NCIMB 1T NCIMB, Aberdeen 
VIB 498 Laboratory collection 
Rainbow trout, Australia 
VIB 502 Laboratory collection 
Salmon, Norway 
VIB 503 Laboratory collection 
Salmon, Norway 
VIB 505 Laboratory collection, Sea 
bass, Norway 
VIB 506 Laboratory collection, Sole, 
Norway 
VIB 507 Laboratory collection 
Turbot, Norway 
VIB 594 Laboratory collection 
Seawater, Sweden 
VIB 595 Laboratory collection 
Seawater, Sweden 
VIB 683 Laboratory collection 
Oyster, Spain 
VIB 684 Laboratory collection 
Oyster, Spain 
VIB 685 Laboratory collection 
Oyster, Spain  
V. cyclitrophicus LMG 21359T NCIMB, Aberdeen 
LMG 21580 Laboratory collection 
V. anguillarum   VIB 01 Laboratory collection 
VIB 11 Laboratory collection, Sea 
bass, Greece 
VIB 5 Laboratory collection   
VIB 118 Laboratory collection   
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VIB 119 Laboratory collection   
VIB 227 Laboratory collection   
VIB 549 Laboratory collection   
VIB 550 Laboratory collection   
VIB 551 Laboratory collection   
B03064 Laboratory collection 
V. alginolyticus LMG 4408T Laboratory collection 
V. cincinnatiensis LMG 7891T Laboratory collection 
V. harveyi NCIMB 1280T  Laboratory collection 
VIB 645 Laboratory collection, Sea 
bass, Tunisia 
0802 Laboratory collection 
V. hollisae CIP 101886T Laboratory collection 
V. natriegens LMG 10935T Laboratory collection 
V. nereis LMG 3895T Laboratory collection 
V. ordalli LMG 13544T Laboratory collection 
VIB 02 Laboratory collection 
V. parahaemolyticus LMG 2850T Laboratory collection 
V. proteolyticus LMG 3772T Laboratory collection 
V. salmonicida MT 1584 Laboratory collection 
V. tapetis 102 Laboratory collection, 
Crab, Ireland 
127 Laboratory collection 
Unidentified strains V1 to V14 This study 
LMG = Laboratorium voor Microbiologie, Ghent, Belgium; NCIMB = National Collection 
for Industrial, Marine and Food Bacteria, Aberdeen. 
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2.2.6.3 Phage genome analysis 
As all the known tailed phages have double stranded linear DNA as their genomes 
(Ackermann, 2011), in this study, according to the morphology, the two virbiophages 
were assumed to have DNA genomes. A phenol-chloroform method modified from 
Pickard (2009) was used for phage DNA extraction. Briefly, 600 μL of sterile propagate 
phage lysate was transferred into a 1.5 mL Eppendorf, and 6 μL of 1 mg mL-1 DNase I 
and 2.6 μL of 12.5 mg mL-1 RNase A were added into the phage lysate, and incubated 
at 37 ℃  for 30 min to remove bacterial genomic contaminants. In a further incubation 
at 58 ℃ for 1 hour, 15 μL of 20 % SDS and 6 μL of 10 mg mL-1 proteinase K were added 
to the Eppendorf tube. Then the phage sample was extracted with 0.5 mL of 
phenol:chloroform:isoamyl alcohol (25:24:1), and spun at 14,000 x g for 15 min to 
separate the phases. The top aqueous phase was removed into a fresh tube, and the 
above extraction step was repeated once, followed by a further extraction step using 
chloroform:isoamyl alcohol (24:1). The aqueous phase was transferred to a new 
Eppendorf tube, and 45 μL of 3 M sodium acetate (pH 5.2) and 500 μL of 100 % 
isopropanol were added to precipitate the DNA at room temperature for 30 min. The 
tube was spun at 14,000 x g for 20 min and then the DNA pellet was washed twice 
with 70 % ethanol prior to air drying. Finally, the phage DNA was resuspended with 50 
μL of nuclease-free water and stored at 4 ℃. 
 
For analysing the phage genome size, five restriction endonucleases Hind III, Xba I, Spe 
I, EcoR I and EcoR V (purchased from Thermo Scientific, UK) were used to digest the 
phage genome DNA, respectively. The reaction was carried out in 20 μL volume and 
incubated overnight at 37 ℃. Restricted DNA products were analysed using 0.8 % 
agarose gel electrophoresis and visualised using UV light. Lamada DNA/Hind III Marker 
(Thermo Scientific) was used as the comparison. The electrophoretogram was 
analysed by using Quantity One® (BIO-RAD) software to determine the sizes of 
restricted DNA fragments.   
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2.3 Results 
2.3.1 Bacterial isolates from marine fish farm  
In total, 14 pure bacterial cultures were isolated and preserved in cryopreservant at      
-70 ℃ according to their colony morphology on TCBS+N plates, and referred to as V1 
to V14. Two of these isolates, V9 and V13, were chosen as the indicator bacteria for 
phage assays, as plaques were observed on their lawns during phage isolation, but not 
the lawns of other isolates. Further identification and characterisation of V9 and V13 
were carried out. 
2.3.2 Phenotypic characterisation of Vibrio spp. V9 and V13 
On TCBS+N plates, the colonies of V9 were round, smooth and green, whereas the 
colonies of V13 were yellow (Figure 2.1a). On TNA plates, both V9 and V13 formed 
round, smooth and creamy colonies, but the colonies of V13 were pinkish (Figure 2.1b). 
Isolates V9 and V13 were Gram negative, motile, oxidase positive rods that were 
facultative anaerobic and sensitive to the vibriostatic agent O/129 (10 and 150 μg). 
The API 20E profiles of V9 and V13 were 0066104 and 3062125, respectively (Table 
2.3). 
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Figure 2.1 Colony morphology of Vibrio spp. cultures on the plates of thiosulphate 
citrate bile salts sucrose agar supplemented with 3 % (w/v) NaCl (A) and tryptone soya 
agar with 3 % (w/v) NaCl (TNA) (B). The plates growing V. splendidus V9 are on the left, 
and the plates growing V. cyclitrophicus V13 are on the right. 
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Table 2.3 API 20E results of Vibrio spp. isolates V9 and V13. 
Test V9 V13 
O-Nitrophenyl-β-D-Galactosidase (ONPG) - + 
Arginine dihydrolase (ADH) - + 
Lysine decarboxylase (LDC) - - 
Ornithine decarboxylase (ODC) - - 
Citrate (CIT) - - 
H2S production - - 
Urease (URE) - - 
Tryptophane deaminase (TDA) + + 
Indole (IND) + + 
Voges-Proskauer (VP) - - 
Gelatinase (GEL) + + 
Glucose (GLU) + - 
Mannitol (MAN) + + 
Inositol (INO) - - 
Sorbitol (SOR) - - 
Rhamnose (RHA) - - 
Saccharose (SAC) - + 
Melibiose (MEL) - - 
Amygdalin (AMY) - + 
Arabinose (ARA) - - 
+: positive; -: negative; S: sensitive. 
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2.3.3 16S rRNA gene sequences and phylogenetic tree 
By sequencing and homology searching using nucleotide blast, a 1362 base sequence 
of the 16S rRNA gene from V9 was obtained, and showed 100 % similarity with the 
partial sequences from V. splendidus LGP32 chromosome 1 (FM954972) and V. 
splendidus isolate PB1-10rnD 16S rRNA gene (EU091328). In the same way, a 1369 
base sequence of the 16S rRNA gene from V13 was obtained, and showed 100 % 
similarity with the partial sequences from V. cyclitrophicus JM-2012 16S rRNA gene 
(KF488567) and V. cyclitrophicus HS8 16S rRNA gene (KJ396067).  Therefore, V9 and 
V13 were identified as V. splendidus and V. cyclitrophicus, respectively. 
 
A phylogenetic tree was constructed with 16S rRNA gene sequences of V9, V13 and 17 
other Vibrio spp. strains. Both of V9 and V13 were grouped into the Splendidus clade 
of vibrios: V9 clustered into the branch of V. splendidus strains (including the type 
strain V. splendidus LMG 4042T) and V13 clustered into the branch of V. cyclitrophicus 
strains (including the type strain V. cyclitrophicus LMG 21359T), which were 
distinguished from other Vibrio spp (Figure 2.2).  
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Figure 2.2 Phylogenetic tree constructed by the neighbour-joining method based on 
the partial 16S rRNA gene sequences of the isolated bacterial strains V9, V13 and 17 
other Vibrio spp. strains (NCBI accession numbers are indicated in parentheses). Vibrio 
campbellii LMG 11216T and V. harveyi LMG 4044T were used as the outgroup. 
Numbers at nodes indicate the bootstrap percentages derived from 1000 samples. 
Bar=0.5 % sequence divergence. 
2.3.4 Morphology of V. splendidus V9 and V. cyclitrophicus V13  
According to the observation by TEM, V. splendidus V9 and V. cyclitrophicus V13 
shared similar cell morphology: regularly rod-shaped with a slight curve; 
approximately 1.5-2.0 μm long and 0.5 μm wide in size; with a single polar ﬂagellum. 
(Figure 2.3).  
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Figure 2.3 Bacterial cell morphology under transmission electron microscope. (A) 
Vibrio splendidus V9; (B) V. cyclitrophicus V13. Arrows point out the flagella. 
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2.3.5 Extracellular enzymes 
Both V. splendidus V9 and V. cyclitrophicus V13 showed haemolysin, gelatinase, lipase 
and protease activities. Vibrio splendidus V9 secreted β haemolysin by presenting 
complete lysis of blood cells, whereas V. cyclitrophicus V13 secreted α haemolysin by 
presenting incomplete lysis of blood cells. After adding saturated ammonium sulphate 
to precipitate protein, clear zones appeared around both of the colonies of V9 and V13 
on the gelatin plate. Zones of precipitation of salts with fatty acids appeared around 
both of the colonies of V9 and V13 on the tween 80 plate. A clear zone also appeared 
around the colony of V13 on the skim milk plate, whereas only a very thin clear ring 
was around the V9 colony, which showed a weak positive result (Figure 2.4).  
 
Figure 2.4 Extracellular enzymatic activity tests of (A) haemolysin, (B) gelatinase, (C) 
lipase and (D) protease. The colonies of Virbio splendidus V9 are on the left side, and 
the colonies of V. cyclitrophicus V13 are on the right side of the plates. 
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2.3.6 Temperature and salinity range of growth 
Vibrio splendidus V9 was observed to grow on TNA plates at all the incubation 
temperatures, i.e. 4 to 37 ℃, on different days. Vibrio cyclitrophicus V13 grew on TNA 
plates at all the incubation temperatures since day 1. 
 
Vibrio splendidus V9 grew in 0.5 % to 7 % (w/v) NaCl, whereas V. cyclitrophicus V13 
grew in 0.5 % to 9 % (w/v) NaCl.  
2.3.7 Virulence genes 
The virulence genes, vsm and ompU, were detected by PCR to confirm the possible 
pathogenicity of the V. splendidus isolate V9. Neither vsm nor ompU was amplified 
from the genomic DNA of V9. Both of the genes were amplified from the V. splendidus 
type strain NCIMB 1T (Figure 2.5), and identities of the PCR products were confirmed 
by sequencing and homology searching using nucleotide blast of NCBI. 
  
Figure 2.5 Detection of virulence genes vsm and ompU in Virbio splendidus strains: M. 
100 bp DNA Ladder; Lanes 1. Product of vsm amplified from V. splendidus isolate V9; 2. 
Product of vsm amplified from V. splendidus NCIMB 1T; 3. Product of ompU amplified 
from V. splendidus isolate V9; 4. Product of ompU amplified from V. splendidus 
NCIMB1T. 
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2.3.8 Pathogenicity to rainbow trout 
After three passages, V. splendidus V9 and V. cyclitrophicus V13 were recovered from 
the fish organs and their identities were confirmed. None of the three fish used in the 
passages of V13 showed morbidity/mortality or any clinical signs of disease. Thus, V13 
was considered to be non-pathogenic to rainbow trout, and not included in the 
challenge study. The first two fish for the passages of V9, did not die nor show 
morbidity, whereas the third fish was moribund 24 hours post injection, and showed 
clinical signs of disease including sluggish behaviour, inappetence, darkened pigment, 
and distended abdomen. On sampling, ascetic fluid in the abdominal cavity, swollen 
spleen, swollen intestine containing yellow fluid, haemorrhaging on kidney were 
observed. Based on this result, V9 was used in the following challenge study in 
rainbow trout. 
 
In the challenge study, according to the viable bacterial colony count, the 
concentration of V9 preparation injected into the fish was 6 × 107 CFU fish-1. Within 
the 21 days of the challenge, none of the fish died or were moribund, nor showed any 
abnormal behaviour. At the end of the experiment, no external or internal clinical 
signs of disease were observed from the sampled fish including the control group, and 
no bacteria grew on any of the TNA plates sampled from the fish organs. From these 
results, V. splendidus V9 was considered to be non- or of low virulence to rainbow 
trout and the samples collected for histopathology were not processed further.  
2.3.9 Pathogenicity to goldsinny wrasse 
Based on the counting of viable bacterial colonies, the concentration of V9 and V13 
preparations injected into the fish were 2 × 106 CFU fish-1 and 3 × 106 CFU fish-1, 
respectively. No morbidity nor mortality, nor any abnormal behaviour was observed 
within the 14 days of the challenge. At the end of the experiment, only one fish from 
the i.p. injection group of V. cyclitrophicus V13 was slightly swollen around the 
injection site on the abdomen, while the rest of the fish did not show any external nor 
internal clinical signs of disease. No bacteria grew on any of the TNA plates sampled 
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from the fish abdominal cavity, including the plate sampled from the fish mentioned 
above with a swollen abdomen.  
2.3.10 Pathogenicity to Artemia nauplii 
During this challenge study, no dead Artemia nauplii were found in the control group; 
two dead Artemia nauplii were found in the V9 challenge group at 24 hour and 72 
hour, respectively; one dead nauplius was found in the V13 challenge group at 72 hour 
(Table 2.4).  
Table 2.4 The numbers of dead Artemia nauplii in each treatment group in 
pathogenicity experiment (group size = 50), bacterial infection concentration ~ 107 
CFU mL-1. 
 24 h 48 h 72 h Total 
Control group 0 0 0 0/50 
V9 challenge group 1 0 1 2/50 
V13 challenge group 0 0 1 1/50 
  
2.3.11 Phages isolated from the marine fish farm 
Using double agar overlay plaque assay with the 14 bacterial isolated from the same 
marine fish farm sample, two phages were isolated. One of the phages was hosted by 
V. splendidus V9 and named PVS9, the second was hosted by V. cyclitrophicus V13 and 
named PVC13. Both of PVS9 and PVC13 formed clear plaques on bacterial lawns 
(Figure 2.6). 
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Figure 2.6 Double agar overlay plaque assay. (A) The plaques of phage PVS9 on the 
bacterial lawn of Vibrio splendidus V9; (B) The plaques of phage PVC13 on the bacterial 
lawn of V. cyclitrophicus V13. 
2.3.12 Phage morphology  
Both PVS9 and PVC13 were tailed phages and belonged to the order of Caudovirales. 
PVS9 showed a hexagonal head (diameter approximately 60 nm) with a neck, a 
contractile sheath, and a central tube (approximately 120 nm long), which are the 
morphological characteristics of family Myoviridae (Ackermann, 2009b). PVC13 
showed the morphological characteristics of family Siphoviridae (Ackermann, 2009b): 
a hexagonal head (diameter approximately 55 nm) with a noncontractile and relatively 
flexible tail (approximately 120 nm long). A baseplate with spikes was also observed 
on PVC13 (Figure 2.7). 
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Figure 2.7 Phage morphology under transmission electron microscope and 
descriptions in schematic. (A) Vibrio splendidus phage PVS9 with the morphological 
characteristics of family Myoviridae; (B) V. cyclitrophicus phage PVC13 with the 
morphological characteristics of family Siphoviridae.  
2.3.13 Phage host range  
In the host range test, neither of the vibriophages, PVS9 or PVC13, formed plaques on 
any of the tested bacterial strains, including twelve V. splendidus strains, two V. 
cyclitrophicus strains, twenty-five strains from other Vibrio spp., and twelve 
unidentified strains isolated from the same sample with the phages in this study. 
Among all the tested bacterial strains, phages PVS9 and PVC13 only specifically 
infected and lysed V. splendidus V9 and V. cyclitrophicus V13, respectively.    
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2.3.14 Phage genome 
Using the phenol-chloroform method, the genome DNA of V. splendidus phage PVS9 
and V. cyclitrophicus phage PVC13 was extracted. When being digested with the five 
restriction endonucleases, only the PVC13 DNA/Hind III product showed four clear 
bands on electrophoretogram (Figure 2.8). None of the restriction endonucleases 
could digest the genome DNA of PVS9. However, the genome DNA of PVS9 showed a 
very similar position with that of the PVC13 on the electrophoretogram. Analysed by 
Quantity One®, the sizes of the four clear bands from PVC13 DNA/Hind III product 
were approximately 22.1 kb, 9.9 kb, 8.5 kb and 5.5 kb, with the sum of 46 kb.  
 
Figure 2.8 Electrophoretogram showing the genome DNA of vibriophages PVC13 and 
PVS9, and the PVC13 DNA/Hind III product: 1. Lamada DNA/Hind III Marker; 2. PVC13 
DNA/Hind III product; 3. genome DNA of PVC13; 4. genome DNA of PVS9. 
2.4 Discussion 
Phages occupy all the habitats where their bacterial hosts thrive (Skurnik & Strauch, 
2006; Wittebole et al., 2014). Therefore, phages and their bacterial hosts were 
isolated from the same sample. In this study two Vibrio isolates and their phages were 
isolated from a same environmental sample from a Scottish marine fish farm. Others 
have used this strategy for the successful isolation of phages for phage therapy (Vinod 
et al., 2006; Alagappan et al., 2010; Cohen et al., 2013).    
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So far, there have been very few reports of V. splendidus or V. cyclitrophicus phages. 
The study here successfully isolated the lytic phages of these two Vibrio species. 
According to their morphological characteristics, both of PVS9 and PVC13 belonged to 
the tailed phage order Caudovirales, and the families Myoviridae and Siphoviridae, 
respectively. Tailed phages overwhelmingly predominate the currently isolated phages 
(Ackermann, 2011). The situation is the same for vibriophages, where 227 phages are 
tailed phages out of a total of 240 isolates up to 2007 (Ackermann, 2007). Ackermann 
et al. (1984) considered that vibriophages are very heterogenous and some have 
interesting morphological characteristics. In this study, V. cyclitrophicus phage PVC13 
had the structure of a baseplate with spikes, which is believed to be a device for host-
recognition and irreversible adsorption to start an infection (Sciara et al., 2010; 
Yamashita et al., 2011). The baseplate-spike adsorption devices are common in phages 
of the Myoviridae family, and those of coliphage T4 have been extensively studied 
(Thomassen et al., 2003; Rossmann et al., 2004; Sciara et al., 2010). In contrast, the 
devices are rarely observed in Siphoviridae phages, and only a small group of 
lactococcal phages have similar structures (Labrie et al., 2008; Campanacci et al., 2010; 
Sciara et al., 2010). The V. splendidus myophage PVS9 had a fragile tail, because 
phages missing tail sheaths and separated single sheaths were observed in the TEM 
images (data not shown). This may due to the movements of contraction, which lead 
to tail sheaths becoming loose then sliding along and finally off the tails of the phages 
(Ackermann et al., 1984). 
 
Some of the reported vibriophages have fairly broad host ranges. Vibriophage KVP40 
can infect at least 8 Vibrio spp. including V. parahemolyticus, V. alginolyticus, V. 
anguillarum, V. cholera, V. fluvialis, V. mimicus, V. natriegens and V. splendidus (Inoue 
et al., 1995). A Siphoviridae V. harveyi phage lysed all of the 50 V. harveyi strains 
tested in one study (Vinod et al., 2006). Here, V. splendidus phage PVS9 and V. 
cyclitrophicus phage PVC13 only specifically infected and lysed V. splendidus V9 and V. 
cyclitrophicus V13, respectively, which indicated that both of these phages may have 
very narrow host ranges. However, because of the lack of V. cyclitrophicus strains, only 
three were used in the host range test. A larger selection of V. cyclitrophicus strains 
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would need to be tested to confirm this result. A narrow host range may be related to 
using a receptor that rarely presents on most of the bacterial surface. However, the 
method for phage enrichment and isolation used here should benefit phages that have 
relatively broad host ranges, so they can use a larger number of hosts for propagation. 
The case of PVS9 and PVC13 was contrary to this hypothesis; they could not even lyse 
other Vibrio isolates acquired from the same sample. The reasons for acquiring such 
narrow host range phages rather than broad host range phages may be because most 
of the phages in the original environment were in a status of lysogenicity, which would 
result in very low detectable levels of free phages; and the use of the indicator 
bacterial hosts that were isolated from the same sample with the phages. 
 
Steward et al. (2000) suggested that the typical genome DNA sizes of marine phages 
are in the range from 26 kb to > 200 kb. The genome of V. cyclitrophicus phage PVC13 
was determined as ~ 46 kb. As it could be digested by at least one restriction enzyme 
(Hind III), the nature of its nucleic acid was double stranded DNA. However, the 
genome DNA of V. splendidus phage PVS9 could not be digested by any of the five 
restriction enzymes. So far, all reported tailed phages have linear double stranded 
DNA genomes (Ackermann, 2011). Moreover, the genome DNA of PVS9 showed a very 
similar position with that of the PVC13 on the electrophoretogram. Therefore, it is 
likely that the genome DNA of myophage PVS9 is also linear double stranded with a 
size of 46 kb approximately. Five restriction enzymes (Hind III, Xba I, Spe I, EcoR I and 
EcoR V) that have been frequently used in experiments of genetic engineering (Green 
& Sambrook, 2012), especially in digesting bacterial or plasmid DNA, were chosen to 
digest the genome DNA of PVS9 and PVC13 here. However, both of the phage genome 
DNA showed resistance to these restriction enzymes, as PVC13 DNA could only be cut 
by Hind III and PVS9 DNA could not be cut by any of the five enzymes. The reason of 
this result could be that the DNA of PVS9 and PVC13 had evolved faster than the 
bacterial defence systems, so that phage DNA could not be recognised and cleaved by 
the bacterial restriction system that would lead to a successful infection (Tock & 
Dryden, 2005).        
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For the identification of bacterial hosts, conventional phenotype testing was initially 
performed. With characteristics including Gram negative, motile, oxidase positive, 
facultative anaerobic, curved-rod shape, polar flagella, growing on TCBS, and sensitive 
to the vibriostatic agent O/129, both V9 and V13 were classified into the genus Vibrio 
(Buller, 2004). However, due to the phenotypic diversity of Vibrios, the results of the 
API 20 E profile of the two isolates V9 and V13 could not be used to identify to species 
level (according to the API 20 E database from Buller, 2004). Thereafter, 16S rRNA 
gene sequence analysis, a more robust, reproducible and accurate method for 
bacterial identification (Clarridge, 2004) was applied. Homology searching using 
nucleotide blast identified V9 as V. splendidus and V13 as V. cyclitrophicus. Following 
phylogenetic analysis was also applied by constructing a phylogenetic tree. From the 
results, it can be seen that 16S rRNA gene sequence analysis gave more certain and 
reliable results than the conventional phenotype testing in this case, and using of 
phylogenetic tree presented a more clear relationship between V9, V13 and other V. 
splendidus-related species. Therefore, it is suggested that 16S rRNA gene sequence 
analysis is an easier, more direct, and less time consuming method for bacterial 
identification compared with the conventional phenotype testing. 
 
Both Vibrio isolates V9 and V13 showed a relatively wide range of growth temperature 
(4 - 37 ℃ for both) and salinity (0.5 % - 7 % for V9, 0.5 % - 9 % for V13), which suggests 
that they can survive in various environmental conditions, and could exist worldwide. 
In the extracellular enzymatic activity tests, both V9 and V13 showed positive results 
(some were strong, and some were weak) for the detection of haemolysin, gelatinase, 
lipase and protease, which have been considered as important or potential virulence 
factors in Vibrio spp. (Zhang & Austin, 2000; Baffone et al., 2001; Soto-Rodriguez et al., 
2003; Zhang & Austin, 2005). However, the possession of these virulence factors does 
not guarantee an isolate to be pathogenic. It must be confirmed using in vivo animal 
challenges. In this study, three methods were used to estimate the pathogenicity of 
the vibrio isolates to different potential animal hosts: detection of virulence genes for 
bivalves, challenge in potential animal hosts directly for fish, and challenge in animal 
model for crustaceans. 
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In previous studies, extracellular metalloprotease Vsm and outer membrane protein 
OmpU were characterised as important virulence factors of pathogenic V. splendidus 
in infections of bivalves (Le Roux et al., 2007; Binesse et al., 2008; Duperthuy et al., 
2010; Duperthuy et al., 2011; Liu et al, 2013b), but no evidence showed they are 
related with the infections of fish. The Vsm protein is the major toxicity factor in the 
extracellular products (ECPs) of pathogenic V. splendidus (Le Roux et al., 2007; Binesse 
et al., 2008), and ompU contributes to host antimicrobial peptide resistance and plays 
a role in the attachment and invasion of oyster haemocytes (Duperthuy et al., 2010; 
Duperthuy et al., 2011). Vibrio splendidus LGP32, which possesses the virulence genes 
of both vsm and ompU, is an oyster pathogen associated with the summer mortality 
syndrome that dramatically affects the production of Crassostrea gigas oysters 
worldwide (Gay et al., 2004a; b; Duperthuy et al., 2011).  In contrast, a V. splendidus 
strain closely related to LGP32 that lacked the metalloprotease was avirulent to 
oysters (Binesse et al., 2008), and an ompU deletion mutant derived from LGP32 gives 
lower oyster mortalities compared to the wild-type parent strain (Duperthuy et al., 
2010). Liu et al. (2003b) used PCR to detect the virulence genes vsm and ompU in 43 V. 
splendidus isolates isolated from lesions of moribund Yesso scallops (Patinopecten 
yessoensis). Thirty-four isolates were either vsm or ompU positive, eight isolates were 
neither vsm nor ompU positive, and only one isolate named JZ6 showed positive 
results for both of vsm and ompU detection. In their challenge studies, V. splendidus 
TX2, one of the isolates which were both vsm and ompU negative, and JZ6 were 
involved in both injection and immersion challenges to Yesso scallops. JZ6 gave a 
cumulative mortality rate of 80 % and 45 % in injection and immersion challenges, 
respectively, which were significantly higher than that of TX2 and blank control. The 
TX2 isolate only gave 15 % and 8.33 % cumulative mortality rates in injection and 
immersion challenges, respectively, which were no significant differences with that of 
the blank control (Liu et al, 2013b). From these studies, the possession of vsm and/or 
ompU genes can be considered as very important characteristics of pathogenic V. 
splendidus isolates to bivalves. In our study, two primer sets were designed according 
to the sequences of V. splendidus LGP32 to detect the virulence genes vsm and ompU 
in V. splendidus isolate V9, which showed negative results for both of the genes 
detection. Therefore, V9 was considered to be probably non- or low virulent to 
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bivalves, and further investigation using animal challenge study was considered as not 
necessary to be carried out, which saved experimental resource, labour and time.  
 
The V. cyclitrophicus V13 isolate was deemed to be non-pathogenic to rainbow trout 
following passage experiments and was therefore not involved in the further challenge 
study. Injection of V. splendidus V9 into fish caused the third passaged fish to be 
moribund with clinical signs. In the following challenge study, however, when isolate 
V9 was injected into rainbow trout at a concentration of 6 × 107 CFU fish-1 by 
intraperitoneal injection none of the challenged fish died or was moribund. No 
external nor internal clinical signs were observed from the sampled fish, and no 
bacteria were recovered from the fish organs. The results suggested that only when 
injected with a very high dose (> 108 CFU fish-1) can V. splendidus V9 have a chance to 
cause disease and lead to death in rainbow trout. However, when injected with 6 × 107 
CFU fish-1, which was a high concentration, but comparatively lower than the dose 
used in passage >108 CFU fish-1, could not cause disease. This indicates that V. 
splendidus V9 has a very low virulence to rainbow trout. The rainbow trout model was 
used by Austin et al. (2005) to assess the pathogenicity of Vibrio isolates. Two 
members from the Splendidus clade, V. fortis and V. kanaloae, showed high virulence 
to rainbow trout, and both had an LD50 < 10
2 cells fish-1. However, the majority of the 
Splendidus clade including V. cyclitrophicus were deemed to be non- or low virulent 
due to few clinical signs only occurring with the highest dose (106 cells fish-1) injected, 
and cultures could not be recovered at all or only poorly at the end of the experiment. 
The finding of V. cyclitrophicus as non- or low virulent in rainbow trout is consistent 
with the results from the study of Austin et al. (2005). In the study of Angulo et al. 
(1994), a V. splendidus biotype I isolate was pathogenic to juvenile rainbow trout with 
a LD50 of 2.2 × 10
4 CFU fish-1 by intraperitoneal injection. According to Angulo et al. 
(1994), a useful characteristic to differentiate V. splendidus biotype I and II isolates is 
their reaction on TCBS agar: biotype I strains form yellow colonies on TCBS agar, 
whereas biotype II strains form green colonies. In the current study, V. splendidus V9 
formed green colonies on TCBS agar, thus it is more closely related to biotype II strains. 
This may be a further reason that the V9 isolate showed low virulence to rainbow 
trout. In another study (Bergh & Samuelsen, 2007), 0.2 mL of an OD600 = 2.0 culture of 
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V. splendidus LP1 was injected intraperitoneally into unvaccinated Atlanic salmon 
(Salmo salar) smolts. No mortality or gross pathological changes were observed, and 
no bacteria were recovered from the kidneys. However, the biotype of V. splendidus 
LP1 was not mentioned.  
 
In the challenge using goldsinny wrasse, with the injection concentrations of 106 CFU 
fish-1, no morbidity/mortality, nor any clinical signs of diseases were observed in any of 
the groups. Only one fish from the i.p. injection group of V. cyclitrophicus V13 was a bit 
swollen around the injection site on the abdomen, but no bacteria were recovered 
from the fish. Both V. splendidus V9 and V. cyclitrophicus V13 were deemed as non-
pathogenic to goldsinny wrasse in this case. Studies have proved the pathogenicity of 
V. splendidus to Corkwing wrasse (Symphodus melops) (Samuelsen et al., 2000; 
Samuelsen et al., 2003; Bergh & Samuelsen, 2007). However, so far there is no 
evidence showing that V. splendidus can cause disease in goldsinny wrasse. Birkbeck & 
Treasurer (2014) found that V. splendidus and closely related bacteria dominated the 
intestinal bacterial flora of goldsinny wrasse larvae, and that they could be pathogenic 
if the general fitness of larvae was depressed. This was one of the reasons that why 
goldsinny wrasse was chosen for the pathogenicity test of Vibrio spp. V9 and V13. And 
another reason for this is that goldsinny wrasse is smaller in size than other species of 
wrasse. In the bath challenge of goldsinny wrasse reported by Bergh & Samuelsen 
(2007), no significant differences in cumulative mortality were found between V. 
splendidus challenged and unchallenged groups. So far, there have been no reports 
about the pathogenicity of V. cyclitrophicus to wrasse.  
 
Artemia is an excellent model organism for studying disease in crustaceans, as it can 
easily be cultured in gnotobiotic conditions (Sung et al., 2009). In the study of Soto-
Rodriguez et al. (2003), Artemia franciscana nauplii were used to estimate the 
pathogenicity of luminous vibrios. Artemia nauplii were exposed to 105 to 106 CFU mL-1 
bacterial inoculations for 1 hour and then kept for 48 hours, and the pathogenic 
isolates caused significant mortality rates from 35 % to 80 % (Soto-Rodriguez et al., 
2003). Austin et al. (2005) used rainbow trout and Artemia nauplii to determine the 
pathogenicity of 56 isolates representing 26 species of vibrios. Artemia nauplii were 
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incubated in bacterial concentrations of 106 cells mL-1 for 4 days, and the high virulent 
isolates caused 75 % -100 % mortality rates (Austin et al., 2005). In the current study, 
bacterial concentrations of 107 CFU mL-1 were used to incubate Artemia nauplii for 48 
hours. At the end of the challenge, only 4 % and 2 % mortality rates were caused by V. 
splendidus V9 and V. cyclitrophicus V13, respectively. Hence, both of V9 and V13 were 
regarded as non- or low virulent to Artemia nauplii.  
 
So far, some models of vibriophage therapy using aquaculture animals have been 
successfully set up, and examples include: a V. harveyi phage improving shrimp 
(Penaeus monodon) larval survival (Vinod et al., 2006); a V. parahaemolyticus phage 
preventing vibriosis in Artemia franciscana (Martínez-Díaz & Hipólito-Morales, 2013); 
and a V. anguillarum phage increasing survival of Atlantic salmon with vibriosis 
(Higuera et al., 2013). Here, two Vibrio isolates with their phages were successfully 
isolated. Unfortunately, both of the bacterial hosts showed non- or low virulence to 
the animals tested in this study. Thus, an in vivo phage therapy model could not be set 
up using these Vibrio isolates and their phages. However, according to previous 
studies (Angulo et al. 1994; Gatesoupe et al., 1999; Jensen et al., 2003; Beaz-Hidalgo et 
al., 2008a; Reid et al., 2009), turbot and cod larvae, and corkwing wrasse may be 
useful as future challenge models for determining the pathogenicity of V. splendidus 
V9. Bivalve models may also be worth testing for the pathogenicity of V. cyclitrophicus 
V13. Using virulent bacterial strains whose pathogenicity has been well studied to 
isolate phages may provide a more direct approach to set up phage therapy models 
and so this was pursued in Chapter 3. 
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3.1 Introduction 
Aeromonas salmonicida subsp. salmonicida generally referred to as typical A. 
salmonicida is the causative agent of furunculosis which is a systemic disease of 
salmonid fish and has caused significant economic losses in worldwide aquaculture 
(Bernoth, 1997; Burr & Frey, 2007; Dallaire-Dufresne et al., 2014). The use of vaccines 
and antibiotics has been generally successful in preventing the disease and stopping 
heavy mortalities during outbreaks of furunculosis, respectively. However, the 
applications of vaccines have also shown a number of adverse effects (Midtlyng, 1996; 
Mutoloki et al., 2004; Sørum & Damsgård, 2004; Berg et al., 2006; Haugarvoll et al., 
2010; Satoh et al., 2011), and using antibiotics leads to the rapid emergence of 
antibiotic resistant bacteria and the potential retention of the compounds in fish 
products destined for human consumption (Reith et al., 2008; Kim et al., 2011; Austin 
& Austin, 2012; Vega-Sánchez et al., 2014; Coscelli et al., 2015). 
 
Using phages as bioagents is an alternative approach for the treatment or prophylaxis 
of bacterial infectious diseases in aquaculture (Nakai & Park, 2002). Since Nakai and 
Park with their colleagues initiated the exploration of the potential of using phage 
therapy in aquaculture (Park et al., 1997; 1998; Nakai et al., 1999; Park et al., 2000; 
Park & Nakai, 2003), more and more bacterial pathogens and aquaculture animals 
have been involved in this practice worldwide. However, so far, only a few attempts 
have been made on the experimental applications of phage therapy to control A. 
salmonicida infections (Imbeault et al., 2006; Verner-Jeffreys et al., 2007; Kim et al., 
2015). 
 
In this study, two phages of a pathogenic A. salmonicida strain were isolated and 
characterised. Their abilities to inhibit A. salmonicida growth in vitro, as well as the 
efficiency of phage therapy against A. salmonicida infections in a rainbow trout model 
were investigated.  
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3.2 Materials and methods 
All the media and chemicals were purchased from Oxoid (Basingstoke, UK), and Sigma-
Aldrich (Basingstoke, UK), respectively, unless otherwise stated. 
3.2.1 Sample collection  
A water sample (100 mL) was collected using a 250 mL sterile laboratory capped bottle 
(Fisherbrand, UK) from the outlet pond of a Scottish fresh water fish farm in July 2012. 
The water temperature was 13 ℃.  
3.2.2 Culture of bacteria 
The A. salmonicida strains used in this study were cultured on TSA plates at 22 ℃ or in 
TSB at 22 ℃ with orbital vibration at 140 rpm, except the cultures used for challenge 
experiments which were incubated at 15 ℃. The methods used for preparing bacterial 
suspension for challenges were the same as Section 2.2.5.2. 
3.2.3 Enrichment and isolation of A. salmonicida phages 
Pathogenic A. salmonicida subsp. salmonicida Hooke (Vivas et al., 2004), was obtained 
from the collection of Bacteriology Laboratory, University of Stirling, and used as the 
host in the phage enrichment process. This strain was isolated from rainbow trout in 
England in 1991 by Professor Brian Austin. The method used was similar to Section 
2.2.3, except 1 mL of A. salmonicida Hooke fresh culture was added into the water 
sample and TSB mixture, which then was incubated at 22 ℃, 140 rpm for 24 hours. 
 
The double agar overlay plaque assay as Section 2.2.3 was used for phage isolation, 
purification and enumeration, except the media used were TSA and TSB, and the 
temperature for incubation was 22 ℃. Aeromonas salmonicida Hooke was used as the 
indicator bacterial strain.  
 
As the A. salmonicida phages in this study replicated poorly in liquid broth (data not 
shown), a soft-agar method adapted from Fortier & Moineau (2009) was used for 
phage propagation, and also the preparations of phage for stocking and in vivo 
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injections. Firstly, the double agar overlay TSA plates were made following the same 
method for phage isolation, but with a greater number of phage aimed for complete 
lysis. The plates were incubated at 22 ℃ for 18-24 hour, and then the top agar was 
scraped and transferred into a centrifuge tube by a sterile spreader. The bottom plates 
were rinsed with 0.5 mL of phage SM buffer to recover residual phages and 
transferred into the same centrifuge tube. The supernatant was removed following 
one centrifugation at 4,000 x g for 10 min. Finally, the phage suspension was 
harvested by another centrifugation at 4,000 x g for 10 min and filtration through 
sterile 0. 20 μm filters. The methods for phage preservation were the same as 
described in Section 2.2.3. 
3.2.4 Phage morphology observation by TEM 
The filtered propagated phage suspensions were used for morphology observations by 
TEM following the negative staining method as described in Section 2.2.6.1.   
3.2.5 Host range test  
In the phage host range test, 15 A. salmonicida subsp. salmonicida strains and 2 A. 
hydrophila strains, which were either from the laboratory collection or purchased from 
the National Collection of Industrial, Marine and Food Bacteria (NCIMB), were 
included (Table 3.1). The spot test method of Section 2.2.6.2 was applied here, and 
Aeromonas salmonicida subsp. salmonicida strain Hooke was used as the positive 
control.  
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Table 3.1 Bacterial strains used for phage host range test. 
Identification Collection Number A-layer  Source  
Aeromonas 
salmonicida subsp. 
salmonicida 
Hooke + Laboratory collection, 
England, 1991     
NCIMB 1102T - Purchased from NCIMB                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
MT 004 - Laboratory collection,    
Ellis et al., 1988; 
MT 423 + Laboratory collection,  
Hirst & Ellis, 1994 
Fy undetermined Laboratory collection 
Scotland 
N5 undetermined Laboratory collection  
Scotland 
76 undetermined Laboratory collection 
Atlantic salmon, 
England 1976  
LL undetermined Laboratory collection, 
salmon farm, Scotland 
B01004 undetermined Laboratory collection 
rainbow trout, Farm 
code 1 Scotland, 2001  
B99106 undetermined Laboratory collection 
rainbow trout, Farm 
code 2 Scotland, 1999 
B99109 undetermined Laboratory collection 
Atlantic salmon, Farm 
code 3, Scotland, 1999 
B05050 undetermined Laboratory collection 
rainbow trout, Farm 
code 4 Scotland, 2005 
B02085(1) undetermined Laboratory collection 
Atlantic salmon, Farm 
code 5, Scotland, 2002 
B05059 undetermined Laboratory collection, 
cod Farm code 6 
Scotland, 2005 
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B04061 undetermined Laboratory collection, 
cod Farm code 7 
Scotland,2004 
B99059 undetermined Laboratory collection 
brown trout, Farm code 
1 Scotland, 1999 
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+: positive; -: negative; n/a: not applicable.                                                                                 
NCIMB = National Collection of Industrial, Marine and Food Bacteria, Aberdeen.              
Farm code, the location of the farms is confidential but randomly allocated numerical 
codes were provided per isolate to indicate that these had been recovered from 
different clinical outbreaks in different farm locations.  
3.2.6 Determination of phage genome size by pulsed field gel electrophoresis 
(PFGE) 
Phage genome sizes were determined using PFGE, because it saves the steps of phage 
DNA extraction and endonuclease digestion, when compared with the restriction 
endonuclease analysis. The methods were modified from Sambrook & Russell (2001) 
and Bartie et al. (2012). Briefly, 1 μL of DNase I (1 μg mL-1) was added to 10 μL of 
phage suspension and the mixture was incubated at 37 ℃ for 30 min. Then 4 μL of 2.5 
x SDS-EDTA Dye Mix (0.4 % (v/v) of 20 % (w/v) SDS solution, 30 mM EDTA, 0.25 % (w/v) 
bromophenol blue, 0.25 % (w/v) xylene cyanol FF, 20 % (w/v) sucrose) was added, and 
the mixture was incubated at 65 ℃ for 5 min. Samples were stored at 4 ℃ until use.  
 
Samples were loaded into separate wells of 1% agarose gel (Gibco, UK), which was run 
using a Rotaphor (R) Type V system (Biometra, UK) in 0.25 x TBE at 14 ℃, 6 V cm-1 and 
a 120 O angle for 20 hours with a 2-10 s switch time and rotor speed of 9. Lambda PFG 
Ladder (NEB, UK) and Lamada DNA/Hind III Marker (Thermo Scientific) were used as 
the molecular size markers. The gels were stained with 0.5 ug/mL ethidium bromide 
solution for 30 min and de-stained in distilled water for 10 min. Finally, the gel was 
visualised using UV light.     
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3.2.7 In vitro test of phage inhibition on A. salmonicida 
Aeromonas salmonicida Hooke, and A. salmonicida phages pAS-3 and pAS-6 were 
involved in this experiment. Phage preparation and fresh bacterial broth culture were 
co-inoculated in 250 μL of TSB at MOI = 1,000. The cultures were incubated with 
shaking at 140 rpm and 22 ℃. In the bacterial growth control group, containing only 
sterile phage SM buffer was inoculated with bacteria. TSB without any inoculum was 
used as the blank control to monitor for any contaminations. Each treatment had four 
replicates. The experiment was carried out using 96-well flat bottom microplates 
(SARSTEDT, UK), which were read at OD600 every hour using a microplate reader 
(Synergy HT, BioTek, UK) from 0-18 hour. 
3.2.8 In vivo trials in rainbow trout 
All the juvenile rainbow trout used in the following challenge trials were from a same 
fish farm in Scotland. The conditions for keeping the fish, the methods for preparing 
bacterial inoculums and the passages of A. salmonicida Hooke, were the same as 
described in Section 2.2.5.1, except that for A. salmonicida Hooke OD600 = 0.2 was 
equal to approximately 1 x 108 CFU mL-1. All the injections in these trials were 
intraperitoneal. Phage preparations were tested for sterility by plating onto sterile TSA 
plates and incubating at 22 ℃ for 48 hours, and then checking for bacterial growth.  
3.2.8.1 Dose response of A. salmonicida Hooke in rainbow trout 
To estimate the relationship between the concentrations of A. salmonicida Hooke 
injected into rainbow trout and the cumulative moralities of the fish population, 
bacterial concentrations of 1 x 102, 103 and 104 CFU fish-1 were injected into three 
groups of 6 fish per group. Another group of fish were injected with sterile saline as 
controls. The fish were kept for 14 days, and checked four times daily for 
morbidity/mortality. Freshly dead, moribund fish and survivors were observed and 
sampled for external and internal clinical signs of disease and bacterial recovery. 
Recovered bacteria were presumptively identified as the challenge strain by the 
production of a brown diffusible pigment when inoculated onto TSA plates, and 
identification was confirmed using a species specific PCR with the primer set Fer-3 (5’-
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CGGTTTTGGCGCAGTGACG-3’)/Fer-4 (5’-AGGCGCTCGGGTTGGCTATCT-3’), flanking a 
fragment of the fstA gene (coding for the ferric-siderophore receptor) (Beaz-Hidalgo et 
al., 2008b). The PCR reactions were performed in the following conditions: an initial 
denaturation at 95 ℃ for 2 min followed by 30 cycles of denaturation at 95 ℃ for 1 
min, annealing at 60 ℃ for 1 min, and extension at 72 ℃ for 1 min. Then, the reaction 
was completed by extension at 72 ℃ for additional 5 min. 
3.2.8.2 In vivo safety test of phage preparations  
As the raw phage preparations to be used for phage therapy contained bacterial 
components, a safety test was carried out before the trial, to assess whether or not 
the phage preparations of pAS-3 and pAS-6 would cause any mortality or clinical signs 
of diseases in rainbow trout. The safety test used three groups of 5 fish per group. In 
two of the groups, 100 μL of 108 PFU mL-1 pAS-3 or pAS-6 were injected into each 
group, respectively. Sterile phage SM buffer was injected into the control group. The 
fish were kept for 14 days, and checked four times daily for any gross clinical signs of 
disease, and morbidity/mortality which would be further investigated by post-mortem, 
phage and bacterial recovery from kidney, and histopathology. All fish that survived 
were observed and sampled at the end of the experiment for any external or internal 
clinical signs of disease.  
3.2.8.3 Phage therapy against the infection caused by A. salmonicida 
The design of the phage therapy experiment against A. salmonicida Hooke infections 
in rainbow trout is shown in Table 3.2. Aeromonas salmonicida Hooke was injected 
into all the fish using a concentration of 1 x 102 CFU fish-1 which should cause 
approximately 40 % mortality from the previous challenge study (Section 3.2.8.1). 
Phage preparations of pAS-3 or pAS-6 were then immediately injected into two 
treatment groups of fish, respectively, using a MOI=10,000. The reasons for choosing 
MOI=10,000 were: first, using a lower MOI = 1,000 gave a good result of inhibition on 
bacterial growth in vitro, so using MOI=10,000 would be expected to give a better 
inhibition in vivo; and second, using MOI=10,000 meant 1 x 106 PFU fish-1 of phage 
preparation would be injected, this concentration was lower than the one used in the 
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phage preparation safety test, which meant this concentration is supposed to be safe 
for fish. Sterile phage SM buffer was injected into the remaining treatment group. All 
the treatments had three replicates, and 10 fish were included in each replicate. Five 
fish were injected with sterile saline and phage SM buffer only and these were 
negative control. The fish were kept for 14 days, and checked four times daily for 
morbidity/mortality. Freshly dead, moribund fish and 50 % of the survivors from each 
group were sampled for bacterial recovery. Two of the A. salmonicida colonies 
recoved from each fish were selected randomly to test for phage sensitivity using 
phages pAS-3 and pAS-6. 
Table 3.2 Experimental design of the phage therapy trial in rainbow trout 
(concentration of Aeromonas salmonicida Hooke injected = 102 CFU fish-1, multiplicity 
of infection (MOI) = 10,000). 
Treatment group Treatment No. Fish per replicate No. replicates 
1 phage SM buffer  10 3 
2 treated with pAS-3 10 3 
3 treated with pAS-6 10 3 
3.2.9 Statistical analysis 
Minitab software version 16 (Minitab Inc., Pennsylvania) was used in this study to 
perform basic descriptive statistics and comparisons using a significance level of 5% (P 
= 0.05). Prior to analysis, datasets were checked for normality using the Anderson-
Darling test. Post-hoc analyses were carried out using Tukey's multiple comparison 
tests with values considered significantly different at P-values <0.05. Analysis of 
variance (ANOVA) manipulated by general linear models (GLMs) considering treatment 
as a fixed factor was used to analyse cumulative mortalities. 
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3.3 Results 
3.3.1 Aeromonas salmonicida phages 
Using the water sample collected from the outlet pond of a Scottish fresh water fish 
farm and A. salmonicida Hooke as the indicator, two phages were isolated according 
to different plaque morphologies. The phage forming clear plaques was named pAS-3, 
and the phage forming turbid plaques was named pAS-6 (Figure 3.1).  
 
Figure 3.1 Plaque morphology of Aeromonas salmonicida phages using A. salmonicida 
strain Hooke as the indicator. (A) A. salmonicida phage pAS-3 formed clear plaques; (B) 
A. salmonicida phage pAS-6 formed turbid plaques. 
3.3.2 Phage morphology 
Both pAS-3 and pAS-6 were tailed phages and belonged to the order of Caudovirales. 
Phage pAS-3 showed the morphological characteristics of family Siphoviridae 
(Ackermann, 2009b): a hexagonal head (diameter approximately 50 nm) with a 
noncontractile and rigid tail (approximately 100 nm long). Phage pAS-6 showed the 
morphological characteristics of family Podoviridae (Ackermann, 2009b): an 
icosahedral head (diameter approximately 55 nm) with a short tail (Figure 3.2).  
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Figure 3.2 Phage morphology under transmission electron microscope and 
descriptions in schematic. (A) Aeromonas salmonicida phage pAS-3 with the 
morphological characteristics of family Siphoviridae; (B) A. salmonicida phage pAS-6 
with the morphological characteristics of family Podoviridae. Red circles show phage 
positions.  
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3.3.3 Phage host range 
In the host range test, phages pAS-3 and pAS-6 lysed the A. salmonicida strains B01004, 
B99059, B99106 and 76 only. These isolates were all recovered from clinical cases of 
furunculosis in farmed fish in the UK. 
3.3.4 Phage genome size 
The genome DNA of pAS-3 and pAS-6 showed a very similar position which was just a 
little higher than the band of 48.5 kb from Lambda PFG Ladder on the 
electrophoretogram. Therefore, the genome sizes of both A. salmonicida phages pAS-3 
and pAS-6 were determined as approximately 50 kb (Figure 3.3). 
 
Figure 3.3 Electrophoretogram showing the genome DNA sizes of Aeromonas 
salmonicida phages determined by pulsed field gel electrophoresis: 1. Lambda PFG 
Ladder; 2. Lamda DNA/Hind III Marker; 3. genome DNA of pAS-3; 4. genome DNA of 
pAS-6. 
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3.3.5 Inhibition of the growth of A. salmonicida Hooke in vitro 
As shown in Figure 3.4, control inoculations of A. salmonicida Hooke with phage SM 
buffer reached logarithmic phase at 7 hour, and grew continuously to the stationary 
phase with a final OD600 value ≈ 0.6. The inoculations of A. salmonicida Hooke with 
phage pAS-6 showed a similar growth trend to that of the control, but there was some 
inhibition of growth and the culture reached a lower final OD600 value ≈ 0.52. In 
contrast, phage pAS-3 totally inhibited the growth of A. salmonicida Hooke. No 
contamination was observed from the blank control. 
 
Figure 3.4 In vitro test of phage inhibition on the growth of Aeromonas salmonicida 
Hooke. Multiplicity of infection (MOI) = 1,000. The results were shown as mean ± 
standard deviation from four replicates (not all error bars visable). 
3.3.6 Dose response challenge 
At the end of this 14 days A. salmonicida challenge, 2, 5 and 5 fish were dead or 
moribund in the groups that had been injected with concentrations of 1 x 102, 103, 104 
CFU fish-1 generating final mortalities of 33 %, 83 % and 83 %, respectively, with no 
mortalities observed in the uninfected control group (Figure 3.5). Across all the 
challenge groups, mortality commenced at day 3 and ceased by day 8. All the dead or 
 98 
 
moribund fish showed internal clinical signs of haemorrhaging over the abdominal 
walls, viscera and intestinal tract, and bacteria were recovered from the kidney. No 
clinical signs were observed nor were any bacteria recovered from the surviving fish, 
including the control group. All the recovered bacteria produced brown pigment on 
TSA plates and their identity was confirmed as A. salmonicida using specific PCR. 
 
Figure 3.5 Mortality responding in rainbow trout to different injection concentrations 
of Aeromonas salmonicida Hooke. No death happened from day 8-14. 
3.3.7 Safety test of phage preparations 
None of the injected fish died or were moribund during the 14-day safety test of A. 
salmonicida phage pAS-3 and pAS-6 preparations (data not shown). At the end of the 
experiment, no external or internal clinical signs of disease were observed from the 
sampled fish including the control group. 
3.3.8 Phage therapy in rainbow trout model 
At the end of the 14-day phage therapy trial, the cumulative mortalities of the 
treatments with phage SM buffer, phage pAS-3 and phage pAS-6 were 37 %, 17 % and 
27 %, respectively. Mortalities occurred rapidly in the control group from day 3 to day 
6, while this was slower and delayed in the phage treated groups. Mortalities occurred 
from day 4 to day 8, and day 3 to day 10, respectively, in the phage pAS-3 and pAS-6 
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treatment groups (Figure 3.6). There were, however, no significant differences 
between the final cumulative mortalities and time to death of the three treatment 
groups (p>0.05). No fish died in the control group. Bacteria with brown pigmentation 
on TSA were recovered from all the freshly dead or moribund fish, but no bacteria 
were recovered from the survivors. In the phage sensitivity test, all of the selected 
colonies from all the dead or moribund fish were still sensitive to A. salmonicida 
phages pAS-3 and pAS-6. 
 
Figure 3.6 Cumulative mortalities of three treatment groups (phage SM buffer, phage 
pAS-3, phage pAS-6) in the phage therapy trial. 
3.4 Discussion 
An in vivo phage therapy model would not be set up in Chapter 2 due to a lack of 
pathogenicity of the bacterial strains in tested animals. Therefore, a pathogenic A. 
salmonicida subsp. salmonicida Hooke was used as the host to isolate phages. 
Considering the bacterial host was isolated from diseased fish, and any phages isolated 
would be applied in an aquaculture environment, a water sample collected from the 
outlet pond of a Scottish fresh water fish farm was used for phage isolation.  
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A number of A. salmonicida phages have been reported (Paterson et al., 1969; Kim et 
al., 2012a; b; c; d). Based on morphological characteristics, most of them are 
myophages, and only a few are podophages, whereas, to the best of our knowledge, 
no siphophages have been reported. In this study, two A. salmonicida phages were 
isolated. According to their morphological characteristics, pAS-3 was identified as a 
siphophage, and pAS-6 was identified as a podophage. The isolation of these two 
phages enriched the biodiversity of A. salmonicida phages. 
 
In the host range test, both A. salmonicida phages, pAS-3 and pAS-6, were able to lyse 
four out of 15 strains of the A. salmonicida subsp. salmonicida strains tested. These 
four strains were isolated from diseased salmonid fish in the UK, but in different years. 
From these results, it is speculated that both A. salmonicida phage pAS-3 and pAS-6 
have a relatively narrow host range. According to the studies of Kim et al. (2012a; b; d), 
A. salmonicida phages can have a broad host range, or be extremely host specific: A. 
salmonicida myophage PAS-1 showed broad infectivity in all the tested A. salmonicida 
strains (17), and another myophage phiAS5 was able to infect all the tested A. 
salmonicida subsp. salmonicida and subsp. masoucida strains (16), as well as seven A. 
hydrophila strains and one A. sobria strain, whereas A. salmonicida podophage phiAS7 
was only able to infect one of the tested A. salmonicida subsp. salmonicida strains 
tested. 
 
PFGE has been employed to resolve fragments of genomic DNA or whole viral genomic 
DNAs with the range of 0.2 kb to 12 Mb in many research work (Lingohr et al., 2009). 
Thus, in this study, PFGE was applied to detect the genomic DNA sizes of A. 
salmonicida phage pAS-3 and pAS-6. According to the results from PFGE, pAS-3 and 
pAS-6 had genome sizes of approximately 50 kb, which is close to the genome sizes of 
A. salmonicida podophage phiAS7 and myophage PAS-1 (42kb and 48 kb, respectively), 
but much smaller than that of A. salmonicida myophage phiAS4 and phiAS5 (164 kb 
and 225 kb, respectively) (Kim et a., 2012a; b; c; d). 
 
In the in vitro growth inhibition experiment, with the MOI=1,000, pAS-3 successfully 
inhibited the growth of A. salmonicida Hooke during the whole 18 hours experiment, 
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whereas pAS-6 showed a weak ability of inhibiting Hooke growth. To investigate 
whether or not the ability of inhibiting bacterial growth in vitro can reflect the 
efficiency of phage therapy in vivo, both pAS-3 and pAS-6 were tested in a rainbow 
trout in vivo model.  
 
Raw phage preparations of pAS-3 and pAS-6 were used for in vivo phage therapy. The 
reasons for not highly purifying the phages using CsCl density gradient centrifugation 
were: firstly, the particle production of pAS-3 and pAS-6 were relatively low, so it will 
be very hard to have a visible band of phage after the centrifugation; secondly, the 
steps of carrying out CsCl density gradient centrifugation are complicated and there is 
a danger of chemical poisoning from CsCl. Considering that raw phage preparations 
may contain bacterial components which may be harmful to fish and cause clinical 
signs or even mortality, in vivo safety tests of the raw phage preparations were 
conducted using a small number of rainbow trout before starting the phage therapy 
trial. One hundred microlitres of raw phage preparation was injected into fish by i.p. at 
a concentration of 107 PFU fish-1. No mortality or any clinical signs of diseases were 
observed in the injected fish during 14 days. This showed that it was safe to administer 
the raw phage preparations to fish by i.p., which is consistent with Verner-Jeffreys et 
al. (2007): even though bacterial endotoxins were present at 106-107 Endotoxin Units 
per milliliter (EU mL-1) in the raw preparations of A. salmonicida phages, no adverse 
effects were observed in the Atlantic salmon injected by i.p. with 0.1 mL of the raw 
phage preparations containing a phage concentration of 108 PUF mL-1 up to 42 days 
post-injection.   
 
The optimum growth temperature of A. salmonicida is between 22 and 25 ℃. 
However, some studies have reported that even growing A. salmonicida in this 
optimum temperature range may lead to the loss or inactivation of some virulence 
genes (Ishiguro et al., 1981; Stuber et al., 2003; Daher et al., 2011). To maintain the 
virulence of A. salmonicida Hooke, cultures were incubated at 15 ℃, and this was also 
the same temperature for keeping fish in the challenge trials. In the does response 
trial, a bacterial concentration of 1 x 103 CFU fish-1 led to mortalities in 5 out of 6 fish, 
which illustrated that A. salmonicida Hooke was very virulent to rainbow trout with an 
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LC50 of < 1 x 10
3 CFU fish-1. As A. salmonicida Hooke was so virulent, a concentration of 
≥ 1 x 103 CFU fish-1 may lead to a very high mortality, and this would overwhelm the 
effectiveness of phage therapy. Therefore, a lower concentration of 1 x 102 CFU fish-1 
was chosen to use in the therapy trial, aiming to acquire a total mortality of 
approximately 40 % in the control fish group (without phage treatment). 
 
Considering the results from in vitro inhibition where pAS-3 completely inhibited 
Hooke growth in 18 hours with an MOI=1,000, a higher MOI=10,000 was used in the 
phage therapy trial to try to achieve better inhibition in vivo. This MOI value was also 
used by Kim et al. (2015) in their study of using phage against A. salmonicida infections 
in rainbow trout showing notable protective effects. Studies of Nakai et al. (1999) and 
Verner-Jeffreys et al. (2007) also showed that the early receiving phage treatment post 
bacterial challenge, the better protective effects could be had. Therefore, in this work, 
phage preparation was injected immediately after the bacterial challenge. 
 
According to the results, the groups treated with phages pAS-3 and pAS-6 showed low 
of mortality and postponed time of death compared with the SM buffer treated 
control group. However, there were no statistically significant differences between the 
cumulative mortalities and time to death of the phage treated and untreated control 
groups. The results may be attributed to the following reasons. First, the bacterial 
concentration used in this study may be too low to show effective phage protection. 
Most of the phage therapy studies in fish by i.p. used bacterial concentrations which 
caused 100 % or nearly 100% mortalities in control fish group (Nakai et al., 1999; 
Verner-Jeffreys et al., 2007; Mahmoud & Nakai, 2012; Kim et al, 2015), so that even if 
a small number of fish survived in the phage treatment groups, the protection may be 
significant. However, in the work of Jun et al. (2013), phage treatment gave a 100 % 
protection on cyprinid loach when the bacterial concentration used caused 40 % 
mortality in the non-treatment control group. Second, the bacterial components in the 
raw phage preparations may reduce the activity of phages in the therapy. Verner-
Jeffreys et al. (2007) also used raw phage preparations in their phage therapy trial, 
where phage treatment and non-treatment control groups had the same mortalities at 
the end of the experiment (MOI = 190,000). In contrast, Kim et al. (2015), using highly 
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purified phage preparations, led to 25 % survival rate in the phage treatment group 
whereas 0 % survival rate incurred in non-treatment control group (MOI = 10,000). 
Third, the fish group size used in this study was relatively small, so that it would be 
very hard to obtain statistically significant differences between the cumulative 
mortalities of the phage treated and untreated groups. The latter may be the most 
likely explanation and therefore the phage therapy experiment should be repeated 
with larger groups of fish.  
 
Two of A. salmonicida colonies recovered from each died or moribund fish during the 
phage therapy trial were randomly selected for phage sensitivity test. All of them were 
still sensitive to the phages, i.e. no phage resistance was detected. Beside the 
possibility that no phage resistance happened during the experiment, the number of 
colonies selected for phage sensitivity test may not big enough to detect the phage-
resistant mutants, as the resistance may just happen in a small portion of the 
recovered bacteria. Furthermore, the resistant mutants may remain the same 
phenotype with the sensitive colonies, which results the difficulty of identifying the 
mutants from a mix culture of both resistant and sensitive colonies. The mechanisms 
that confer protection against bacteriophages are still unclear. In the study of Verner-
Jeffreys et al. (2007), although a phage cocktail of three phages were used in the 
phage therapy experiment, a ‘light’, more translucent, phenotype of A. salmonicida 
was recovered and showed resistance to all the three phages. Noteworthily, the 
resistant isolates were not only isolated from the phage treatment groups, but also 
the untreated challenge control fish, which indicated that the presence of 
bacteriophage was not necessary to initiate resistance. 
  
From the results of this present study, there seems to be a correlation between the 
plaque morphology, the ability of inhibiting bacterial growth in vitro, and the efficiency 
of controlling bacterial infections in vivo, although the latter could not be proven 
statistically. Aeromonas salmonicida phage pAS-6 formed turbid plaques on bacterial 
lawn, weakly inhibited the growth of A. salmonicida Hooke in vitro, and showed a low 
efficiency of controlling A. salmonicida infections in vivo, whereas phage pAS-3 formed 
clear plaques, inhibited A. salmonicida Hooke completely in vitro, and showed a better 
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efficiency of phage therapy in vivo. Thus, it is speculated that phages forming clear 
plaques and showing high ability to inhibit bacterial growth in vitro, may also give 
greater efficiency for controlling bacterial infections in vivo, and influence the choice 
of phages for phage therapy in future. 
 
To date, only a few attempts have been made to demonstrate the experimental 
applications of phage therapy to control A. salmonicida subsp. salmonicida infections, 
and effectiveness is still controversial: in a rainbow trout (i.m. injection) model (Kim et 
al., 2015), significant protective efficacy of phages was observed, whereas in a brook 
trout (water-borne) model (Imbeault et al., 2006) and an Atlantic salmon (i.p. injection) 
model (Verner-Jeffreys et al., 2007), only a delay in the onset of infection was 
observed. Therefore, in this study, an in vivo model was set up to estimate the 
effectiveness of phage therapy to against A. salmonicida subsp. salmonicida infections 
in rainbow trout. Under our experimental conditions, the phage treated and non-
treated groups did not show significant differences in the final cumulative mortalities 
and the time to death. Future studies to improve this work should focus on choosing a 
more appropriate bacterial concentration for challenges, enhancing the purity of 
phage preparations, and using a larger number of fish per experimental group.  
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4.1 Introduction 
The increasing incidence of infections that are due to antibiotic resistant bacteria (Levy 
& Marshall, 2004; Bush et al., 2011; Bragg et al., 2014) has led to renewed interest in 
bacteriophages and bacteriophage therapy. Phages have the advantage of existing in 
abundance in nature and being easily isolated. They replicate and decline along with 
bacterial growth, kill specific bacteria, and co-evolve with their bacterial hosts (Loc-
Carrillo & Abedon, 2011; Oliveira, et al., 2012). Precisely because of these advantages, 
a number of phage therapy trials have already been successfully carried out to control 
bacterial diseases in plants (Balogh et al., 2010), poultry (Huff, et al., 2002, 2003), 
livestock (Johnson et al., 2008), humans (Abedon, et al., 2011; Chanishvili, 2012), and 
animals in aquaculture (Nakai & Park, 2002; Oliveira, et al., 2012; Higuera, et al., 2013; 
Richards, 2014; Rao & Lalitha, 2015).  
 
However, phage therapy also has its limitations (Skurnik & Strauch, 2006; Loc-Carrillo 
& Abedon, 2011; Oliveira, et al., 2012), including major concerns about the emergence 
of phage-resistant mutants generated during therapy (Gill & Hyman, 2010; Labrie, et 
al., 2010). These phage-resistance mechanisms include preventing phage adsorption, 
preventing phage DNA entry, cutting phage nucleic acids, and the abortive infection 
systems i.e. interference can be made at different steps required for a successful 
infection of a phage (Hyman & Abedon, 2010; Labrie, et al., 2010). These mechanisms, 
however, are still not well understood. Among then, one system which acts by 
specifically cleaving the incoming phage DNA as it enters the host cells, namely the 
CRISPR-Cas systems (Clustered Regularly Interspaced Short Palindromic Repeats loci, 
coupled to CRISPR-associated genes) is considered to provide adaptive immunity to 
prokaryotes using sequence memory to target invading DNA (Dupuis et al., 2013; Attar, 
2015). Due to the different reasons leading to phage-resistance, changes related with 
characteristics and virulence may occur in a bacterium (Guglielmotti et al., 2006; 
Stoddard et al., 2007; Capparelli et al., 2010b). Therefore, better understanding of the 
generation and characteristics of phage-resistant bacterial mutants, and estimating 
the change of virulence compared with the parental wild-type strains, is important and 
critical for the success of phage therapy.  
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Nowadays, insects are widely used as feasible and convenient model systems to 
evaluate virulence of numerous human pathogens. The greater wax moth (Galleria 
mellonella) larvae have the advantages of low costs, convenient injection, they require 
little space or specialist infrastructure, they are an ethically acceptable animal model, 
and can be reared over a wide temperature range (Mukherjee et al., 2011; Desbois & 
Coote, 2012). Numerous studies have successfully used the greater wax moth larvae 
model for various purposes including testing of antimicrobial agents (Desbois & Coote, 
2011; Hill et al., 2014), estimating virulence of pathogenic bacteria (Jander et al., 2000; 
Silver et al., 2011; Evans & Rozen, 2012), testing of immune response testing 
(Schuhmann et al., 2003), and even phage therapy (Hall et al., 2012; Abbasifar et al., 
2014). Here, we applied this model to assess virulence of A. salmonicida strains, as a 
previous study has shown that fish pathogen virulence can be reliably assessed in the 
greater wax moth larvae (McMillan et al., 2015).  
 
In Chapter 3, two Aeromonas salmonicida phages, pAS-3 and pAS-6 were isolated and 
used in an in vivo phage therapy model against A. salmonicida infections in rainbow 
trout. No phage-resistant mutants were isolated either from the dead or moribund 
fish, or from the surviving fish at the end of the experiment. In this chapter, phage-
resistant mutants of A. salmonicida Hooke were induced by repeating challenges with 
phage pAS-3, and then the characteristics and virulence of a selected mutant was 
studied and compared with the wild-type A. salmonicida strain in order to (i) 
understand the generation and characteristics of the pAS-3 induced phage-resistant 
mutants of A. salmonicida; and (ii) estimate the consequence of using A. salmonicida 
phage pAS-3 in phage therapy when phage-resistant mutant cells emerge. 
4.2 Materials and methods 
All the media and chemicals were purchased from Oxoid (Basingstoke, UK), and Sigma-
Aldrich (Basingstoke, UK), respectively, unless otherwise stated. 
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4.2.1 Induction of phage-resistant mutants in vitro 
To induce phage-resistant mutants, 10 μL of fresh overnight culture of A. salmonicida 
wild-type strain Hooke was added to 1 mL pAS-3 preparation (~ 107pfu mL-1), then 
incubated overnight in a Kuhner shaker incubator (ISF-1-W, Switzerland) at 15 ℃, 140 
rpm. After 24 hours, 50 μL of the mixture was aseptically spread onto a TSA plate, 
which was incubated at 15 ℃ for 2 days. A loopful of the mixture was picked and 
streaked onto a fresh TSA plate to allow growth of single colonies, which then were 
purified and marked for a phage-sensitivity test using the spot testing method (Kutter, 
2009) with A. salmonicida phages pAS-3 and pAS-6. If all the generated bacterial 
strains were still sensitive to the phages, the above procedure would be repeated for 
another round, until at least one of the generated strains showed negative results (no 
plaques formed) in the phage-sensitivity test, which meant that phage-resistant 
mutants had been acquired. The mutants were stored on preservation beads 
(Technical Service Consultant Ltd, UK) at -70 ℃. One of the phage-resistant mutants, 
termed HM, was chosen for the subsequent analysis. 
4.2.2 Identification of the phage-resistant mutant  
The conventional tests, excluding O/129 test for bacterial identification were 
performed following the methods described in Chapter 2 (Section 2.2.4.1).  
 
The A. salmonicida specific primer set Fer-3/Fer-4 (Beaz-Hidalgo et al., 2008b) was 
used to confirm the identity of the phage-resistant mutant. The PCR conditions 
consisted of an initial denaturation step at 95 ℃ for 10 min followed by 30 cycles of 
amplification at 95 ℃ for 1 min, 60 ℃ for 1 min and 72 ℃ for 50 sec, then the reaction 
was completed by a final elongation step of 72 ℃ for 5 min. The PCR products were 
analysed using 1.2 % (w/v) agarose gel (containing 0.5 μg mL-1 ethidium bromide) 
electrophoresis at 80 V for 40 min and visualised under UV light using a 
transilluminator (Syngene, BioImaging). 
 
Aeromonas salmonicida wild-type strain Hooke was used as the control in all the 
above tests.  
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4.2.3 Growth temperature range and colony morphology 
Single colonies of Hooke and HM were aseptically streaked onto TSA plates, which 
were then incubated at 4 ℃, 15 ℃, 22 ℃ and 30 ℃, and observed for colony 
morphology every 24 hours for 7 days.  
4.2.4 A-layer detection 
To detect the A-layer protein, HM was streaked onto plates of Coomassie Brilliant Blue 
agar (TSA supplemented with 0.01 % (w/v) Coomassie Brilliant Blue R250) (Cipriano & 
Bertolini, 1988) and Congo Red agar (TSA supplemented with 0.02 % w/v congo red 
and 0.15 % bile salts) (Ishiguro et al., 1985; Bashar, et al., 2011), which two methods 
have been used in many studies for A-layer detection, but never been compared in a 
same study. The plates were incubated at 15 ℃ for 3-5 days. A-layer positive strains 
produce dark blue colonies on Coomassie Brilliant Blue agar, and red-coloured 
colonies on Congo Red agar, whereas the A-layer negative strains are not stained. The 
Hooke strain was used as the positive control in the tests.  
4.2.5 Autoagglutination test  
A single colony of HM was inoculated into a sterile round bottom test tube containing 
5 mL of TSB. After overnight incubation with shaking at 15 ℃, 140 rpm, the tube was 
incubated for 3-6 hours at 15 ℃. Bacterial autoagglutination was indicated by the 
presence of visible cell clumps at the bottom of the tube, as observed by the naked 
eye. Aeromonas salmonicida Hooke was used as a positive control in the test.  
4.2.6 Observation of bacterial ultra-thin sections by transmission electron 
microscopy (TEM) 
Overnight cultures of HM cells in TSB were harvested by centrifugation (1-14 
Microfuge, Sigma) at 5,000 x g for 5 min,  and fixed in 1.5 mL of 2.5 % (v/v) 
glutaraldehyde overnight at 4 °C, followed by washing twice with 0.1 M sodium 
cacodylate buffer (pH 7.2). The fixed cell pellets were stored at 4 °C until they were 
post-fixed in 1 % (w/v) osmium buffer in closed vials for 1 hour at room temperature.  
The following steps of preparing the bacterial ultr-thin sections were conducted by the 
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technician Mr. Linton Brown. The pellets were then washed for 3 x 5 min with distilled 
water. ‘En-bloc’ staining was undertaken with 2 % (w/v) uranyl acetate in 30 % 
acetone in dark for 1 hour, after which the pellets were dehydrated through an 
acetone series of ascending concentrations (60 %, 90 % and 100 %) at room 
temperature. Pellets were then infiltrated with agar low viscosity resin (ALVR) on a 
rotator (Taab, UK), following which the pellets were finally embedded in green block 
moulds and polymerised in oven at 60 °C overnight. Ultra-thin sections at 100 μm 
thickness were prepared from the resin blocks using a microtome (Reichert Ultracut E, 
Leica, UK) and placed on 200 square mesh Formvar-coated copper grids. The sections 
were observed under a Philips (FEI) CM120 Biotwin Transmission Electron Microscope 
(TEM). Hooke was processed in the same way and used as comparison.  
4.2.7 Antibiotic sensitivity assay 
The procedure was modified from the Kirby-Bauer agar disc diffusion method (Bauer 
et al., 1996). The overnight broth culture of HM was adjusted to OD600 of 0.5 using a 
spectrophotometer (2041, Cecil, UK), of which 100 μL was aseptically spread onto a 
TSA plate. Antibiotic discs (Oxoid) of amoxicillin (AML, 10 μg), enrofloxacin (ENR, 5 μg), 
florfenicol (FFC, 30 μg), oxolinic acid (OA, 2 μg), oxytetracycline (OT, 30 μg) and 
sulphamethoxazole (SXT, 25 μg) were applied, and the diameters of the inhibition 
zones were measured after 48 hours of incubation at 15 ℃. The cut-off points for the 
antibiotic sensitivity profiles were: 0-10 mm in diameter = resistant, 11-15 mm in 
diameter = partial sensitivity, >16 mm in diameter = sensitive. Aeromonas salmonicida 
Hooke was used as comparison, and this experiment was repeated twice.  
4.2.8 Virulence assessment using the greater wax moth larvae model    
Freshly purchased greater wax moth larvae (UK Waxworms Limited) were used as the 
model to assess the virulence of the parental A. salmonicida wild-type strain Hooke 
and the phage-resistant mutant HM. Two hundred and twenty larvae were randomly 
divided into 11 groups, each comprising 20 larvae. The groups were injected in the last 
left proleg using a 50 μL Hamilton syringe with 10 μL of the A. salmonicida wild-type 
strain Hooke cells (103, 104, 105, 106 and 107 CFU mL-1), the phage-resistant mutant HM 
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cells (103, 104, 105, 106 and 107 CFU mL-1) or sterile saline, respectively (the wild and 
mutant cells were resuspended with sterile saline). The infected larvae were then kept 
in sterile petri dishes for 48 hours at 15 ℃. Dead larvae were removed from the petri 
dishes, and the mortality of each group was recorded every 24 hours. The 
concentrations of the injected bacterial preparations were calculated using the Miles 
& Misra viable bacterial colony count method (Miles et al., 1938). The LC50 values were 
calculated using the Probit analysis method (Sakuma, 1998) with IBM SPSS V19. 
Bacteria were recovered from the haemolymph of dead larvae using Aeromonas 
Medium Base with Ampicillin Selective Supplement following the manufacturer’s 
instruction to avoid the contamination from the original microflora of the moth larvae. 
Both A. salmonicida Hooke and HM grew on the Aeromonas Medium agar plates 
before the challenge. The identification of Hooke and HM recovered from the larvae 
was carried out by PCR amplification using the specific primer set (Fer-3/Fer-4) for A. 
salmonicida and phage-sensitivity test using phages pAS-3 and pAS-6. 
4.3 Results 
4.3.1 Acquisition of phage-resistant mutants in vitro 
Aeromonas salmonicida wild-type strain Hooke was challenged by A. salmonicida 
phage pAS-3 to induce A. salmonicida phage-resistant mutants. In the second round of 
induction, three single colonies were picked randomly and purified on TSA plates. All 
of these three acquired strains showed resistance to both A. salmonicida phages pAS-3 
and pAS-6 in the phage-sensitivity test, whereas the parental wild-type strain Hooke 
showed sensitivity (Figure 4.1). The three phage-resistant cultures were regarded as 
phage-resistant mutants. One of the three mutants, named HM, was chosen to be 
used in subsequent experiments.    
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Figure 4.1 Phage-sensitivity tests of Aeromonas salmonicida strains HM and Hooke 
using A. salmonicida phages pAS-3 and pAS-6. Visible plaques formed on the bacterial 
lawn of A. salmonicida strain Hooke (A), whereas no plaques formed on that of HM 
(B). 
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4.3.2 Identification of HM as a A. salmonicida Hooke phage-resistant mutant 
In the identification tests, HM gave a series of the same results with A. salmonicida 
Hooke: Gram negative short rods, non-motile, oxidase positive, facultative anaerobic 
and API 20E profile of 6206104 (ADH, LDC, CIT, GEL, GLU, MAN and OX were positive, 
the rest of the tests were negative). 
 
In the molecular identification tests, the expected 422 bp PCR amplification products 
of A. salmonicida specific primer set (Fer-3/Fer-4) were visualised on the gel from both 
HM and Hooke genomic DNA (Figure 4.2).   
 
Figure 4.2 Identification of the Aeromonas salmonicida mutant HM by PCR using A. 
salmonicida specific primer set (Fer-3/Fer-4): 1. DNA Ladder; 2. Amplicon from the 
genomic DNA of phage-resistant mutant HM; 3. Amplsicon from the genomic DNA of 
wild-type strain Hooke; 4. Blank control no DNA template. 
4.3.3 Growth temperature range 
In the growth temperature range experiment, both A. salmonicida HM and Hooke 
grew at all the test temperatures (4 ℃, 15 ℃, 22 ℃ and 30 ℃). As observed by 
morphological differences in colony presentation, when incubated at the lower 
temperatures (4 ℃ and 15 ℃), HM and Hooke had similar sizes of colonies; whereas 
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when incubated at the higher temperatures (22 ℃ and 30 ℃), HM formed larger 
colonies than Hooke within the same incubation time (Figure 4.3), especially at 30 ℃, 
at which Hooke barely grew, but HM grew well. In this test, 22 ℃ was regarded as the 
optimum growth temperature for both Hooke and HM. 
  
Both Hooke and HM A. salmonicida strains produced diffusible brown pigment on TSA 
plates at 15 and 22 ℃. However, the colonies from Hooke were regarded as ‘rough’, 
while colonies from HM were regarded as ‘smooth’ (Figure 4.3).  
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Figure 4.3 Colony morphology of Aeromonas salmonicida wild-type strain Hooke (A) 
and phage-resistant mutant HM (B) on TSA plates incubated at 22 ℃ for 3 days. 
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4.3.4 Detection of A-layer  
Aeromonas salmonicida strains Hooke and HM were inoculated onto Coomassie 
Brilliant Blue agar and Congo Red agar plates to detect the presence of A-layer protein. 
Aeromonas salmonicida Hooke produced dark blue colonies on Coomassie Brilliant 
Blue agar, whereas HM produced creamy colonies (Figure 4.4A), which indicated that 
the latter was A-layer negative. Both Hooke and HM formed red-coloured colonies on 
Congo Red agar, although the colour of HM colonies was slightly lighter than that of 
Hooke colonies, which indicated A-layer positive results for both of the wild-type strain 
and the mutant (Figure 4.4B). 
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Figure 4.4 Detection of Aeromonas salmonicida A-layer: (A) phage-resistant mutant 
HM (left) and wild-type strain Hooke (right) on Coomassie Brilliant Blue agar; (B) HM 
(left) and Hooke (right) on Congo Red agar. 
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4.3.5 Autoagglutination ability  
After standing in the 15 ℃ incubator for 3-6 hours, the wild-type strain A. salmonicida 
Hooke formed visible cell clumps at the bottom of the test tube, while the phage-
resistant mutant HM formed a homogeneous cell suspension in TSB medium, 
indicating that the autoagglutination ability of HM decreased dramatically compared 
with the wild-type strain Hooke (Figure 4.5). Autoagglutination is associated with the 
presence of A-layer (Ishiguro et al., 1981; Evenberg et al., 1982). 
 
Figure 4.5 The autoagglutination phenotype: (A) Aeromonas salmonicida phage-
resistant mutant HM did not autoagglutinate, forming a homogeneous cell suspension 
and (B) A. salmonicida wild-type strain Hooke autoagglutinated, forming visible cell 
clumps on the bottom of the test tube. 
4.3.6 Bacterial cell morphological comparison of A. salmonicida Hooke and 
HM under TEM 
The ultra-thin sections of both A. salmonicida Hooke and HM were observed by 
transmission electron microscopy (TEM) at a magnification of X 15,000. No obvious 
difference was observed from the inner cell areas. However, a layer of thick and furry 
structure (considered as the A-layer) was observed on the surface of A. salmonicida 
wild-type strain (Hooke) cells, whereas this structure appeared to be very thin or 
absent at some parts of the phage-resistant mutant (HM) cells, indicating a 
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degradation of A-layer on the A. salmonicida phage-resistant mutant (HM) cells. 
Moreover, gaps between the outer membrane and plasma membrane were observed 
from the HM cells, i.e. expansions of the periplasmic space were observed, where the 
furry outer membrane structure completely disappeared (Figure 4.6).  
 
Figure 4.6 Bacterial cell morphology of Aeromonas salmonicida wild-type strain Hooke 
and phage-resistant mutant HM under transmission electron microscope. (A) wild-type 
strain Hooke, arrow indicates the outer membrane structure (A-layer); (B) phage-
resistant mutant HM, arrows indicate the missing of A-layer, ‘G’ indicates the enlarged 
periplasmic space. 
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4.3.7 Antibiotic sensitivity 
In the antibiotic sensitivity assay, A. salmonicida HM and Hooke showed the same 
sensitivities to all six antibiotics tested. Both were resistant to oxytetracycline (30 μg), 
but sensitive to amoxicillin (10 μg), enrofloxacin (5 μg), florfenicol (30 μg), oxolinic acid 
(2 μg) and sulphamethoxazole (25 μg) (Table 4.1).   
Table 4.1 Antibiotic sensitivity results of Aeromonas salmonicida wild-type strain 
Hooke and phage-resistant mutant HM. 
Antibiotics (μg) Hooke HM 
Oxytetracycline (30) R R 
Amoxicillin (10) S S 
Enrofloxacin (5) S S 
Florfenicol (30) S S 
Oxolinic acid (2) S S 
Sulphamethoxazole (25) S S 
R: resistant; S: sensitive.  
μg = microgram; information in brackets is the concentration of antibiotic per disc. 
4.3.8 Virulence of A. salmonicida strains  
A serial of dilutions of A. salmonicida Hooke and HM were injected into the greater 
wax moth larvae to assess the virulence. At the end point, i.e. 48 hours post-injection, 
the LC50 of Hooke and HM were 6.46 x 10
4 and 2.66 x 104 CFU larva-1, respectively 
(Table 4.2). The dead larvae turned dark brown or black, whereas the larvae that 
survived were a light creamy colour. Aeromonas salmonicida Hooke and HM were 
both isolated from the haemolymph of dead larvae in pure culture on the Aeromonas 
selective medium plates. The identities of recovered A. salmonicida Hooke and HM 
were confirmed by the specific PCR products of 422 bp, and phage-sensitivity 
characters (recovered Hooke and HM were still phage-sensitive and phage-resistant, 
respectively).  The group injected with sterile saline remained alive throughout the 
experiment. 
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Table 4.2 The LC50 of Aeromonas salmonicida wild-type strain Hooke and phage-
resistant mutant HM to the greater wax moth larvae at 48 hours post-injection (group 
size per concentration=20). 
Group 
Concentration  
(CFU larva-1) 
Mortality (%) 
LC50  
(CFU larva-1) 
Hooke 
    8.0 x 100     0 
   6.46 x 104 
8.0 x 101 0 
8.0 x 102 5 
8.0 x 103     15 
8.0 x 104     65 
HM 
2.0 x 101 5 
2.66 x 104 
2.0 x 102     10 
    2.0 x 103    35 
2.0 x 104    100 
2.0 x 105    100 
Sterile saline       10 μL 0 - 
LC50: lethal dose 50%; % = percentage. 
4.4 Discussion 
In this study, phage-resistant mutants derived from the pathogenic A. salmonicida 
strain Hooke were induced by repeating challenges using A. salmonicida lytic phage 
pAS-3. To imitate the aquatic environment, induction in liquid medium was chosen 
and considered to be simpler to acquire phage-resistant mutants than using solid agar. 
Other similar liquid induction methods, including one termed secondary culture 
technique, have been used in many studies to obtain phage-resistant mutants 
(Quiberoni et al., 1998; Guglielmotti et al., 2006; Stoddard et al., 2007).     
 
In this study, the characteristics of A. salmonicida phage-resistant mutant HM and the 
wild-type strain Hooke were compared. Although the strains showed the same 
sensitivity to 6 antibiotics tested, they differed for other parameters. Differences were 
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shown in that the phage resistant mutant formed ‘smooth’ colonies on TSA, did not 
autoagglutinate, formed creamy colonies on Coomassie Brilliant Blue agar and showed 
the degradation of a thick/furry layer structure on the cell surface under TEM, all 
indicating a deficiency of the A-layer (Ishiguro et al., 1981; Cipriano & Bertolini, 1988; 
Bernoth, 1990; Austin & Austin, 2012). However, the phage-resistant mutant HM 
formed red colonies on Congo Red agar as did the wild-type strain Hooke. It indicates 
that Congo Red agar may not be as sensitive as Coomassie Brilliant Blue agar for 
detecting a deficiency of the A-layer of A. salmonicida. Expansion of the periplasmic 
space was observed in the phage-resistant mutant HM cells, where the A-layer 
structure had disappeared completely. It is speculated that the components related 
with the assembly of the A-layer were blocked in the periplasmic space, and could not 
be transferred to the surface of the outer membrane, which led to the deficiency of 
the A-layer (Belland & Truse, 1985).        
 
An earlier study (Ishiguro et al., 1984) reported that the A-layer may act as a phage 
receptor, since phage TP446 adsorbed to all of the tested A. salmonicida strains that 
possessed the A-layer, but failed to adsorb to mutants lacking the A-layer. On the 
other hand, studies by Rodgers et al. (1981) and Ishiguro et al. (1983) reported that 
cell wall lipopolysaccharide (LPS) is a phage receptor, or at least related with A. 
salmonicida phage adsorption, as extracted LPS from A. salmonicida could inactivate 
phages, and mutants shown to be defective in LPS structure, were also resistant to the 
phages. Dooley et al. (1989) believed that the assembly of the A-layer required the 
presence of O-polysaccharide chains from LPS, indicating that changes of LPS can also 
lead to the deficiency of the  A-layer on the cell surface. Therefore, it is deduced in this 
study that the A-layer either directly acted as the receptor of A. salmonicida phage 
pAS-3, or was affected indirectly by the change of an unknown phage receptor.  
 
In this study, a phenomenon of cross-resistance was observed: the A. salmonicida 
phage-resistant mutant HM induced by challenging with the phage pAS-3, also 
acquired the resistance to phage pAS-6. It is speculated that phages pAS-3 and pAS-6 
may share a same receptor on their A. salmonicida host, or at least the changing or 
absence of the receptor used by pAS-3 has a negative effect on the receptor used by 
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pAS-6. According to Chapter 3, pAS-3 and pAS-6 were isolated from a same 
environmental sample; pAS-3 was identified as a Siphoviridae phage, whereas pAS-6 
was identified as a Podoviridae phage. Therefore, hypotheses are made that tailed 
phages from different families can use a same receptor on the bacterial host surface; 
moreover pAS-3 and pAS-6 may be in a competitive relationship in the natural 
environment.  
 
Based on the functional similarity in the innate immune responses to invasive infection 
between insects and fish, McMillan et al. (2015) performed work with 11 wild-type 
isolates of V. anguillarum an important fish pathogen, and found the virulence of 
these isolates correlated positively and significantly in the greater wax moth larvae 
and Atlantic salmon infection models. Their work showed that the greater wax moth 
larva could be a suitable alternative host for studying virulence of fish pathogens. Thus, 
in this study, the virulence of A. salmonicida strains was assessed using the greater 
wax moth larvae model. This model could be considered as a reliable reflection of the 
virulence of these A. salmonicida strains in fish (rainbow trout), but future work is 
needed to confirm this. Moreover, this experiment of virulence assessment in the 
greater wax moth larvae model was only carried out once with no replicates. 
Therefore, the results should be confirmed by repeating the experiment with 
additional replicates. 
 
Here, the A. salmonicida phage-resistant mutant HM showed a deficiency in the A-
layer, and no decline of virulence in the greater wax moth larvae model when 
compared with its parental wild-type strain Hooke. The A-layer is one of the important 
virulence factors of A. salmonicida, and some early studies have reported an 
association between the possession of the A-layer and virulence (Udey & Fryer, 1978; 
Ishiguro et al., 1981; Kay et al., 1981). However, other work carried out by Adams et al. 
(1988), Ellis et al. (1988) and Bernoth (1990) indicated that A-layer negative stains can 
also cause mortality in rainbow trout. Therefore, presence of the A-layer cannot be 
considered as a reliable indicator of virulence of A. salmonicida. 
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The mechanisms of phage-resistance are complicated (Hyman & Abedon, 2010; Labrie, 
et al., 2010). In this study, it is likely that the generation of the phage-resistant 
mutants was due to the absence of the phage receptor on the cell surface. However, 
this hypothesis needs to be proven by further work, e.g. testing phage sensitivity on 
spontaneous or engineered A-layer negative A. salmonicida Hooke mutant, or testing 
whether or not phages pAS-3 and pAS-6 can be inactivate by purified A-layer protein.  
Moreover, the fact that the mutant HM remained resistant after single-colony 
purification and in the absence of phage pAS-3 suggests that the phage resistance was 
inheritable, i.e. a genetic change, but not a physiological response (Stoddard et al., 
2007).       
 
Although in Chapter 3 phage-resistant mutants were not isolated in the phage therapy 
experiment against A. salmonicida infections in rainbow trout, there is still the 
possibility that phage-resistant mutants may be found in further in vivo applications. In 
the study of Verner-Jeffreys et al. (2007), phage-resistant mutants had a more 
translucent phenotype when recovered from fish that died during the phage therapy 
trial, and still appeared to be A-layer positive. Thus, the A. salmonicida phage-resistant 
mutant HM was induced by challenging with phage pAS-3, and the characteristics 
were compared with that of the parental wild-type strain Hooke. The mutant showed 
a better ability than the parental strain to grow at higher temperatures (22 ℃ and 
30 ℃), but no obvious difference at 15 ℃ or below, which is the more suitable water 
temperature for rearing rainbow trout compared with 22 ℃. Therefore, at the lower 
end of the fish rearing temperature, the conditions will not favour the growth of the 
phage-resistant mutant cells from this study. Moreover, the phage-resistant mutant 
HM showed A-layer deficiency, but its virulence did not decline when tested using the 
wax moth larvae model. Although, some studies have reported that phage-resistant 
bacteria frequently have reduced or lost virulence (Smith & Huggins, 1983; Park et al., 
2000; Capparelli et al., 2010a; Laanto et al., 2012), no declind in virulence of the 
phage-resistant mutant HM from this study indicates the importance of fully testing 
the virulence of phage-resistant mutants before carrying out large scale field trials of 
phage therapy. 
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5.1 Overview of this study 
Bacteriophages are a subgroup of prokaryotic viruses that specifically invade bacterial 
cells. Not long after their discovery in 1917, they were applied as antibacterial agents 
against bacterial infections in animals and humans. However, due to the discovery and 
widespread application of antibiotics, many institutes stopped their research on phage 
therapies (Sulakvelidze et al., 2001; Summers, 2001). The increasing incidence of 
infections due to antibiotic resistant bacteria has led to renewed interest in phages 
and phage therapy. Although phage therapy has been applied to control bacterial 
diseases in plants, poultry, livestock and humans, applications in aquaculture are still 
relatively limited.  
 
Some Vibrio spp., especially V. anguilarum, V. salmonicida, V. harveyi and V. tapetis, 
are known bacterial pathogens that cause diseases in aquatic animals (e.g. fish, 
crustaceans and molluscs) (Daniels & Shafaie, 2000; Austin, 2010; Austin & Austin, 
2012; Romalde et al., 2013). These diseases caused by the genus Vibrio, named 
vibriosis, have brought enormous economic loss to the worldwide aquaculture 
industry (Liu et al., 2013a). As phages occupy all the habitats where their bacterial 
hosts thrive (Skurnik & Strauch, 2006; Wittebole et al., 2014), in Chapter 2, the work 
started with isolating lytic vibriophages and their bacterial hosts from a same 
aquaculture environmental sample. Two vibriophages (PVS9 and PVC13) and their 
Vibrio hosts (V9 and V13) were successfully isolated, identified and characterised. 
However, these two Vibrio strains showed non- or low virulence to rainbow trout, 
goldsinny wrasse and Artemia in the experiments of pathogenicity determination. An 
in vivo phage therapy model could not be set up using these Vibrio isolates and their 
phages.  
 
Instead in Chapter 3, Aeromonas salmonicida subsp. salmonicida Hooke, whose 
pathogenicity in salmonids had been proven in a number of published and laboratory 
works (Robertson et al., 2000; Vivas et al., 2004; Kim & Austin, 2006; Brunt et al., 2007; 
Scott et al., 2013), was used to isolate phages for phage therapy. Two phages pAS-3 
and pAS-6 were successfully isolated. Rather than doing many studies on the 
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constituent traits, e.g. adsorption rate, burst size, or lysis time, the work in Chapter 3 
focused on the traits i.e. plaque morphology, ability of inhibiting bacterial growth in 
vitro, and the safety of phage preparation, which may be directly related with the 
efficiency of phage therapy. Using A. salmonicida strain Hooke and its phages pAS-3 
and pAS-6, an in vivo rainbow trout intraperitoneal injection model was developed. To 
determine the protection afforded by the phages, indicators which included lower 
cumulative mortalities and a delay of time to death in the fish groups provided with 
the phage treatment were used and compared with the control animals. However, in 
this study no significant differences were observed in either of these two indicators 
between the phage treated and untreated control fish groups. Whilst initially 
disappointing it was speculated that the low bacterial concentration used, the low 
purity of phage preparations, and the small number of fish used in the study may have 
compromised the results. Further work is required to refine these challenge factors 
and to fully determine the potential of these phages for use in aquaculture.  
 
Although in Chapter 3, no phage-resistant mutants were isolated from the dead fish, 
the generation of the mutants is still a major concern for phage therapy. For this 
reason, phage-resistant mutants of A. salmonicida Hooke were induced in vitro by 
repeating challenges with phage pAS-3, and then the characteristics and virulence of a 
selected mutant HM were studied and compared with the wild-type A. salmonicida 
strain Hooke. The phage-resistant mutant HM showed A-layer deficiency, but grew 
better at higher temperatures (22 ℃ and 30 ℃), and its virulence did not decline in 
the greater wax moth larvae model. These results indicated the importance of fully 
testing the virulence of phage-resistant mutants before carrying out large scale field 
trials of phage therapy. 
5.2 Future work 
Besides the future work that has been highlighted based on the results from each 
chapter, further research is also required.  
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5.2.1 Further characterisation of phages 
As mentioned above, further studies are required on characterisation of phages. 
Understanding the characteristics, such as adsorption rate, burst size, lysis time, and 
stability may help with improving the efficiency of phage therapy. Moreover, knowing 
a complete genome sequence is very important and especially useful for classifying 
phages and checking for virulence genes (which maybe passed to the bacterial hosts to 
cause diseases in animals); thus whole genome sequencing should be conducted. 
5.2.2 Different administration methods of phages in phage therapy  
Although intraperitoneal injection has been used in many phage therapy studies in fish 
for delivery of phages (Table 1.1), for application in aquaculture immersion (water-
borne) or oral (adding phages in the feed) administration may prove more convenient 
and cost effective. Several studies have been conducted comparing the efficiency of 
these different administration methods (Nakai et al, 1999; Verner-Jeffreys et al., 2007; 
Prasad et al., 2011; Jun et al., 2013). However, there is still a lack of experimental data, 
which is needed for a better understanding of these delivery methods. 
5.2.3 Controlling infections caused by atypical Aeromonas salmonicida 
The diseases caused by atypical A. salmonicida in ballan wrasse (Labrus bergylta), one 
of the cleaner fish species being used as a biological control against sealice infections 
in farmed salmon, is currently a major concern in aquaculture in Scotland. One study 
reported that a phage could lyse an atypical A. salmonicida strain (Kim et al., 2012c), 
so using phage therapy in controlling infections caused by atypical A. salmonicida 
would be worth while exploring.  
5.3 Recommendations for improvements in fundamental phage 
research 
During this study, it has been observed that the field of fundamental phage research 
requires some improvements. Therefore, in this section the following 
recommendations are proposed for improvements which would benefit all researchers 
in the field, especially the ones new to working with phages. 
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5.3.1 Enriching the public resource of phages  
In microbiology, establishing, maintaining and enriching collections of microorganisms 
are essential and important for many reasons including the conservation of genetic 
resources, exploring biodiversity, and providing the foundation for scientific research 
and biotechnological processes in industries (Fortier & Moineau, 2009). The same 
holds true for phages. Public phage collections should collect, preserve and distribute 
reference phages for education and research purposes. However, there are only a few 
public collections, including the American Type Culture Collection (www.atcc.org) and 
the German Collection of Microorganisms and Cell Cultures (www.dsmz.de), that have 
phages resource. So far, the only public collection devoted entirely to phages is the 
Félix d'Herelle Reference Center for Bacterial Viruses (www.phage.ulaval.ca) located at 
the Laval University, Quebec, Canada (Fortier & Moineau, 2009). Moreover, the 
amount of phages that have been isolated and studied is very low. The total number of 
phages in the biosphere has been estimated at over 1030 particles (Ackermann, 2011), 
however, from 1959 to 2012, only 6196 phages were reportedly examined by electron 
microscopy (Ackermann & Prangishvili, 2012). Even though, novel phages are 
continually reported at a rate of 100 per year (Ackermann, 2007), this is still not 
sufficient for the increasing demand from various phage research projects and 
applications. Moreover, for many bacteria their phages have not been isolated 
(Ackermann & Prangishvili, 2012).   
 
The Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary 
Science (SEA-PHAGES) project led by Professor Graham Hatfull from the Howard 
Hughes Medical Institute (HHMI), is an inspiring example for the expansion of public 
phage collections. This project began in the autumn of 2008, and has involved over 
4,800 first-year undergraduate students at 73 institutions across the United States. 
The students are trained to isolate and name mycobacteriophages from their own soil 
samples which were collected across and outside the United States, and then the 
phage genomes were sequenced and analysed. Since the start of the programme, 
3,000 new phages have been isolated, and more than 450 mycobacteriophage 
genomes have been sequenced and annotated, and deposited in GenBank and 
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PhagesDB to share with the scientific community (Jorda et al., 2014). This project 
successfully involved introducing undergraduate students in authentic research to 
enhance their interest in biology, and their findings really contribute to the phage 
diversity and phage genomics data base. 
 
Thus, a rich public phage collection with detailed information e.g. sample collection, 
host range, genome sequence, will provide a good resource for selecting candidates 
for phage therapy and other phage works that will directly or indirectly support phage 
therapy research. Researchers can select the phages with the characteristics that they 
need from the collection directly, so that it will save time and materials on phage 
isolation and characterisation. Therefore, new projects should build and enrich the 
phage collections. People who are interested in phage study should be involved in 
these projects, and samples collected from different environments should be used to 
isolate phages. Moreover, sharing phage collections and other phage resources with 
the scientific community would benefit the whole field of phage research.   
5.3.2 Publishing a phage atlas 
According to Ackermann (2011), over 96 % of the phages that have been isolated are 
tailed. It may be that the tailed phages are more numerous than other phages in 
nature, so that they are easier to isolate. However, there is another reason that should 
be considered: the tailed phages have notable morphological characteristics, i.e. 
icosahedral heads and tails, because of this, they are much easier to recognise than 
the phages without notable and unique morphological characteristics. When using a 
phage sample that is not highly purified (as in this study where phage lysates were 
used) for morphology observation, apart from phages, many objects from the bacterial 
cells can also be observed under TEM. For a researcher with insufficient experience 
with phage morphology, it is very hard to identify a non-tailed phage from other 
distractions such as debris from bacterial cells, so that some phages might be omitted 
due to having no typical shape characteristics. Good quality photographs of tailed 
phages observed using TEM can be found relatively easily from the internet, whereas 
photographs of non-tailed phages can be hardly found. Similarly, it is also not easy for 
new researchers to identify phage plaque morphology when isolating phages from 
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environmental samples. Small plaques can be misjudged as air bubbles, oil bubbles, or 
small cracks of agar on the plates. Therefore, an atlas containing TEM photographs of 
different phage morphologies, especially the non-tailed phage ones, and phage plaque 
morphologies would be very helpful for researchers to use for phage isolation and 
identification. However, to the best of my knowledge, there is no such an atlas or 
online repository available. 
5.3.3 Cross-contamination control 
Working with different phages at same time incurs a high risk of cross-contamination 
between these phages, especially for the phages that grow poorly in liquid broth and 
have to be propagated using soft-agar method (such as the A. salmonicida phages in 
Chapter 3). The manipulation steps (e.g. collecting the top agar and transferring to 
centrifuge tubes, and filtration) of preparing phage suspensions are complicated and 
have to be carried out in open spaces rather than closed containers. In Chapter 3, two 
phages having different plaque morphologies (pAS-3 formed clear plaques, pAS-6 
formed turbid plaques) were studied together and therefore any cross-contamination 
was easily detected. However, using morphological characteristics of plaques to 
differentiate phages cannot be effective when phages form similar plaques. Low-cost, 
fast and effective methods have been developed for detecting bacterial cross-
contamination, such as colony morphology, Gram staining, specific PCR, and 
biochemical characteristics. However, there is a general lack of such methods for 
phages. Developing new methods and searching for new characteristics to 
differentiate phages is crucial for detecting new phages and any cross-contamination. 
Meanwhile, careful manipulation, phage-specific laboratory systems, and effective 
disinfection procedure are important for preventing phage cross-contamination.     
5.4 Prospects for phage therapy in aquaculture 
According to the existing research data (Table 1.1), it has been shown that phage 
therapy can be considered as an alternative approach to control bacterial infections in 
aquaculture. However, considering these mixed results, where some bacteria appear 
to be more easily controlled than others, and the total number of bacterial pathogens 
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and the wide range of cultured species in aquaculture, it is clear that this research area 
is still in its infancy, and further studies are needed to be carried out to complement 
the database.  
 
It is likely that phage therapy will not totally replace conventional antibiotic treatment, 
but provide an additional option for treating infections, especially these caused by 
antibiotic-resistant bacteria. Phage therapy provides different routes for phage 
administration to aquaculture animals, which can be chosen according to the realistic 
situations. On-spot treatment is suitable for treating ulcerative skin lesions (Khairnar 
et al., 2013); for deep, systemic infections, injection has been commonly employed; 
however, for larvae, tiny fish, shrimp and shellfish, injection is not feasible, whereas 
immersion, water-borne, or oral administration are more practical. It has been shown 
that higher protection was observed in fish that were first injected with phages and 
then 1 h later injected with the pathogen, than that in the fish were first injected with 
the pathogen and then the phages (Mahmoud & Nakai, 2012). This suggests that 
phages may play a better role in prophylaxis than treatment. However, it is not easy 
for phages to remain in vivo without the presence of the bacterial host, as phages are 
normally cleared by the fish immune system in a few days (Verner-Jeffreys et al., 2007). 
Regularly adding phages in feed and/or farming water to keep a high number of 
phages in the intestinal and water environments may provide a way of prophylaxis.  
Using phage cocktails is widely viewed as a more practical approach than using a single 
phage, which may overcome the limitations of phage resistance and ‘too specific’ 
killing (Richards, 2014). Therefore, phage cocktails are more suitable to be applied in 
the cases of treating multiple infections and preventing secondary infections. 
 
Although, a range of companies specialising in bacteriophages have appeared or 
become established in recent years, demonstrating a growing commercial interest in 
phage therapy, there are still intellectual property (IP) challenges and regulatory 
hurdles which deter investments in phage therapy (Henein, 2013; Verbeken et al., 
2014). In practice, patents on bacteriophage products are important tools for 
attracting investors to new companies keen on developing therapeutic bacteriophages. 
Investing in a product without full IP and particularly patent protection is unlikely to be 
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financially viable (Henein, 2013). Patenting of phages that have been isolated from the 
environment is currently possible, but it provides limited IP protection, as unique 
characters have to be provided to differentiate the patented phage from other phages. 
In addition competitors may easily isolate a same phage from the commercialised 
phage preparation or from the environment where the phage product has been 
applied. Different pathways of patenting in the US and EU also adds to this challenge 
(Pirnay et al., 2012). 
 
The lack of a regulatory framework for developing phage therapy products or using 
phage therapy in real cases is another hurdle in the commercialisation of phage 
therapy. It has raised attention and debates on the uses of phage therapy for humans, 
since it is hard to fit phages into any of the existing category of human medicinal 
products (Pirnay et al., 2012; Henein, 2013; Huys et al., 2013; Verbeken et al., 2014). 
This problem should be the same for phage therapy in aquaculture; however, to the 
best of my knowledge, no literature has discussed it. Different countries may set 
different guidelines for phage therapy in aquaculture, according to their national 
veterinary medicines legislation. However, all the phage therapy products should meet 
the three scientific criteria: quality, safety, and efficacy (Henein, 2013; Verbeken et al., 
2014). Moreover, as the ‘arms race’ between bacteria and phages is ongoing, 
legislation should allow new phages to be quickly used in phage therapy activities and 
products.  
5.5 Other possible applications of phages in aquaculture  
Besides phage therapy, there are other feasible and potential applications of phages, 
which can be applied alone, or in combination with phage therapy in aquaculture.  
5.5.1 Phage and antibiotic synergy  
Both phage therapy and antibiotic treatment have advantages and disadvantages in 
combating bacterial infections. Phages with antibiotic synergy could lead to a better 
treatment effect than when just applyied them independently, as phages and 
antibiotics can give help to each other during the treatment. Comeau et al., (2007) 
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reported that sub-lethal concentrations of certain antibiotics which inhibit bacterial 
cell division and trigger the SOS system can substantially stimulate the host bacterial 
cells to release more virulent phage particles, which could be useful for phage therapy. 
The study of Hagens et al. (2006) revealed that upon infection with filamentous phage 
Pf1, the host Pseudomonas aeruginosa strain showed a significant increase in 
sensitivity to the antibiotics including gentamicin, chloramphenicol and carbenicillin, 
and a P. aeruginosa strain harbouring a plasmid-borne gentamicin resistance gene 
could be resensitised to the antibiotic. Moreover, this study also showed that mice 
were rescued from lethal infections with P. aeruginosa K strain by concomitant 
treatment with phage Pf1 and low concentrations of gentamicin, however, neither 
therapy was able to rescue the mice when applied alone. This study presented a good 
exploration of how phage and antibiotic synergy could be used to combat pathogenic 
bacteria.  
5.5.2 Using phages as biocontrol agents for food safety applications 
Consumption of raw or undercooked seafood is known as a health risk to consumers, 
and bacterial contamination is the main cause of sea-food borne diseases (Iwamoto et 
al., 2010). Fish and fishery products are vulnerable to bacterial contamination, 
especially filter feeders such as mussels and oysters (Popovic et al., 2010). In addition, 
aquatic products may be contaminatedby the marine environment, or during handling, 
processing and preparation (Iwamoto et al., 2010). Therefore, using antimicrobial 
agents to eliminate the contaminations of fishery and aquaculture products is very 
important. The interest in natural antimicrobial compounds has increased due to 
alterations in consumer opinions towards the use of chemical preservatives in 
foodstuff and food processing surfaces (Sillankorva et al., 2012). Phages are naturally 
antimicrobial and their effectiveness in controlling bacterial pathogens in food 
industry has led to the development of different phage products already approved by 
the U.S. Food and Drug Administration (USFDA) (Sillankorva et al., 2012). One of these 
products, bacteriophage Listex P100, has been used to control Listeria monocytogenes 
contaminations of raw salmon and fresh channel catfish fillets (Soni & Nannapaneni, 
2010; Soni et al., 2010).  Moreover, the studies of Rong et al. (2014) and Jun et al. 
(2014) have applied phages to reduce the number of V. parahaemolyticus in oyster 
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processing. Hence, phages can be considered as effective antimicrobial agents to 
control bacterial contaminations in many aquatic products.  
5.5.3 Using phages to manipulate intestinal microbiome of fish 
The human gut microbiome plays crucial nutrition and health roles in metabolic 
functions, influencing the development of the immune system, and protecting from 
colonisation by pathogens (Hooper et al., 2002; Dethlefsen et al., 2007). Although, 
based on the current studies, little is known about the bacterial communities and their 
establishment, or their diversity in fish, it is speculated that the intestinal microbiota in 
fish play similar roles in nutrition and health functions including digestion of algal cells, 
production of amino acids, secretion of inhibitory compounds against colonisation of 
bacterial pathogens, metabolism of dietary substrates, immune system modulation, 
and reproduction and overall population dynamics (Nayak, 2010; Ghanbari et al., 
2015). Therefore, manipulation of the intestinal microbiome can possibly improve the 
overall health status of the host fish, including nutrient digestion, synthesis, 
absorption, pathogen resistance, growth, sexual maturation, morphogenesis, and 
survivorship in stocked fish (Llewellyn et al., 2014).  
 
Phages are known to significantly affect microbial community composition in many 
ecological niches, including the mammalian gut. For example, Enterococcus faecalis 
strain V583 produces a phage øV1/7 which confers an advantage to E. faecalis V583 
during competition with other E. faecalis strains in vitro and in vivo (Duerkop et al., 
2012). This work proposed that E. faecalis V583 uses phage particles to establish and 
maintain dominance of its intestinal niche in the presence of closely related competing 
strains, and therefore, phages can impact the dynamics of bacterial colonisation in the 
mammalian intestinal ecosystem. Another study of Stern et al. (2012) addressed that 
phage-bacterial attack-resistance interactions occur within the human gut microbiome 
and could possibly affect microbiota composition and human health. Although studies 
on phages in the intestinal tract of fish and other aquatic animals have not been 
reported, phage-bacterial interaction may yield new applications of phages in 
aquaculture to manipulate the structure and functions of intestinal microbiomes of 
aquatic animals to improve their health status. 
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5.5.4 Using phage-resistant mutants as vaccines 
The generation of phage-resistant mutants derived from pathogenic bacteria is not 
always bad. In the studies of Capparelli et al. (2010a; b), a phage-resistant attenuated 
mutant A172 of Staphylococcus aureus could confer broad immunity against 
Staphylococcal infection in mice: live A172 cells, its heat-killed vaccine, anti-A172 
mouse antibodies, and the capsular polysaccharide of A172 all afforded significant 
protection from lethal infections of the S. aureus parental strain A170, and antibiotic-
resistant pathogenic S. aureus strains. The results suggested that selection for phage-
resistant mutants can facilitate bacterial vaccine preparations. 
5.5.5 Using phages as vaccine delivery vehicles 
There are two different ways of using phages as potential vaccine delivery vehicles: by 
vaccinating with phages carrying vaccine antigens on their surface or by using phage 
particles to deliver a DNA vaccine expression cassette (Clark & March, 2004a). In the 
former, vaccine antigens can be displayed to a phage surface either by generating a 
transcriptional fusion to a coat protein or by being artificially conjugated (Clark & 
March, 2006). Screening phage-display libraries can provide novel or potential vaccine 
antigents, and conjugating specific antigenic peptides or proteins to the surface of 
phages increases the range of antigens that can be displayed (Clark & March, 2006). In 
the latter, the vaccine gene controlled by a eukaryotic expression cassette is cloned 
into a phage genome, and purified whole phage particles are injected into the host. 
The phage coat protects the vaccine DNA from degradation, and target the vaccine to 
the antigen-presenting cells (Clark & March, 2006). It has been shown that when 
compared with standard DNA vaccines, phage-delivered DNA vaccines are more 
efficient, and superior antibody responses have been shown in animals (Clark & March, 
2004b; March et al., 2004; Clark et al., 2011). The possibility of producing a ‘hybrid 
phage vaccine’ has been proposed, where a DNA vaccine is contained within the same 
phage particle that displaying the variant of the same antigen on the surface. It is 
expected that such a vaccine will efficiently target both the humoral and cellular arms 
of the immune system (Clark & March, 2004a).  
 
 137 
 
Phage vaccination has the advantages of being cheap to manufacture, little technical 
expertise is needed, large numbers of doses can be quickly produced, and multiple 
vaccines can be delivered in one phage (Clark & March, 2004a,b; March et al., 2004; 
Clark et al., 2011). Moreover, because phages (lambda) are very stable at a range of 
temperatures and pH, oral administration of phage-delivered DNA vaccines via 
drinking water may be possible (Jepson & March, 2004), which also means it will be 
suitable for the aqueous environment in aquaculture. 
5.6 Final conclusions  
Different approaches were used to isolate and characterise bacteriophages from two 
aquaculture environments for the studies of phage therapy. A rainbow trout 
intraperitoneal injection model was set up using a pathogenic A. salmonicida strain 
and its two phages. Fish treated with phages showed protection reflected by lower 
cumulative mortalities and a delayed time to death, however, significant differences 
between the treated and control groups could not be demonstrated. Futher work is 
required to determine if these phages have potential in phage therapy. Although the 
culture temperature of some fish species may not favour the emergence of phage-
resistant bacterial mutants during phage therapy, their characteristics, especially 
virulence, still need to be well studied before carrying out large scale field trials. 
Combining the study results from other researchers, it appears feasible to use phage 
therapy as an alternative approach to control bacterial infections in aquaculture, but 
further studies are required to focus on improving effectiveness, and to overcome the 
concrete limitations and hurdles in application and commercialisation. Moreover, a 
broader range of applications of phages in aquaculture should be explored.  
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